Subject: "United States" / Journal: Vaccine / Subject: vaccination and children

1. Physician clinical decision support system prompts and administration of subsequent doses of HPV vaccine: A randomized clinical trial

Author:: Wilkinson, Tracey A.; Dixon, Brian E.; Xiao, Shan; Tu, Wanzhu; Lindsay, Brianna; Sheley, Meena; Dugan, Tamara; Church, Abby; Downs, Stephen M.; Zimet, Gregory
Source:: Vaccine 2019 v.37 no.31 pp. 4414-4418
ISSN:: 0264-410X
Subject:: United States, etc ; adolescents; automation; children; decision support systems; equations; females; health care workers; males; parents; patients; randomized clinical trials; regression analysis; vaccination; vaccines; warts; Show all 16 Subjects
Abstract:: ... HPV vaccine is effective in preventing several cancers and anogenital warts, yet rates of HPV vaccination series completion in the United States are low. A primary reason identified by parents for vaccinating children against HPV is a health care provider’s recommendation. Although most clinicians embrace vaccine recommendations, they are not always carried out evenly and subsequent HPV vaccines a ...
DOI:: 10.1016/j.vaccine.2019.05.004
: https://dx.doi.org/10.1016/j.vaccine.2019.05.004

2. Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia

Author:: Isturiz, Raul E.; Ramirez, Julio; Self, Wesley H.; Grijalva, Carlos G.; Counselman, Francis L.; Volturo, Gregory; Ostrosky-Zeichner, Luis; Peyrani, Paula; Wunderink, Richard G.; Sherwin, Robert; Overcash, J. Scott; Oliva, Senen Pena; File, Thomas; Wiemken, Timothy L.; McLaughlin, John M.; Pride, Michael W.; Gray, Sharon; Alexander, Ronika; Ford, Kimbal D.; Jiang, Qin; Jodar, Luis
Source:: Vaccine 2019 v.37 no.25 pp. 3352-3361
ISSN:: 0264-410X
Subject:: United States, etc ; adults; antigen detection; blood; burden of disease; children; cities; comorbidity; diabetes mellitus; hospitals; issues and policy; monitoring; patients; pneumonia; respiratory system; risk; serotypes; vaccination; vaccines; Show all 19 Subjects
Abstract:: ... Few studies have measured the burden of adult pneumococcal disease after the introduction of 13-valent pneumococcal conjugate vaccine (PCV13) into the US infant vaccination schedule. Further, most data regarding pneumococcal serotypes are derived from invasive pneumococcal disease (IPD), which represents only a fraction of all adult pneumococcal disease burden. Understanding which pneumococcal ser ...
DOI:: 10.1016/j.vaccine.2019.04.087
: https://dx.doi.org/10.1016/j.vaccine.2019.04.087

3. Variation in rotavirus vaccination coding in state US Medicaid data

Author:: Layton, J. Bradley; Butler, Anne M.; Brookhart, M. Alan; Panozzo, Catherine A.
Source:: Vaccine 2019 v.37 no.22 pp. 2892-2895
ISSN:: 0264-410X
Subject:: United States, etc ; Rotavirus; children; edible vaccines; issues and policy; vaccination; Show all 6 Subjects
Abstract:: ... Differences in state Medicaid policies and practices may result in variation in the recording of individual-level vaccination claims, which may present challenges for vaccination research using state Medicaid data. We describe differences in procedure coding for rotavirus vaccination in four states’ Medicaid programs by identifying rotavirus vaccine–specific codes and oral vaccine administration c ...
DOI:: 10.1016/j.vaccine.2019.02.074
: https://dx.doi.org/10.1016/j.vaccine.2019.02.074

4. Associations between population based voting trends during the 2016 US presidential election and adolescent vaccination rates

Author:: Suryadevara, Manika; Bonville, Cynthia A.; Cibula, Donald A.; Domachowske, Joseph B.; Suryadevara, Amar C.
Source:: Vaccine 2019 v.37 no.9 pp. 1160-1167
ISSN:: 0264-410X
Subject:: United States, etc ; adolescents; children; health information; laws and regulations; politics; public health; regression analysis; t-test; vaccination; vaccines; Show all 11 Subjects
Abstract:: ... Politics play a role in the dissemination of public health information, including immunization-related issues. We aim to describe relationships between HPV vaccination rates and state voting patterns during the 2016 US presidential election.We classified each of the 50 states as either “Red” or “Blue,” based on whether a higher proportion of the state’s casted votes were for the Republican or Demo ...
DOI:: 10.1016/j.vaccine.2019.01.036
: https://dx.doi.org/10.1016/j.vaccine.2019.01.036

5. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015–2016

Author:: Milucky, Jennifer; Carvalho, Maria de Gloria; Rouphael, Nadine; Bennett, Nancy M.; Talbot, H.Keipp; Harrison, Lee H.; Farley, Monica M.; Walston, Jeremy; Pimenta, Fabiana; Lessa, Fernanda C.; Bower, Mary; McNair, Nina; Williams, Sabrina; Presmanes, Emily; Tunali, Amy; Thomas, Stephanie; Hollick, Rosemary; Langdon, Jacqueline; Salar Sepehri, Amir; Sharova, Anna
Source:: Vaccine 2019 v.37 no.8 pp. 1094-1100
ISSN:: 0264-410X
Subject:: United States, etc ; Streptococcus pneumoniae; adults; antibiotic resistance; antibiotics; children; cross-sectional studies; quantitative polymerase chain reaction; risk factors; serotypes; vaccination; vaccines; Show all 12 Subjects
Abstract:: ... Vaccination of children with 13-valent pneumococcal conjugate vaccine (PCV13) led to declines in vaccine-type pneumococcal nasopharyngeal carriage among adults through indirect effects. In August 2014, PCV13 immunization of all U.S. adults ≥65 years of age was recommended. This study sought to define prevalence and serotype distribution of pneumococcal carriage among adults ≥65 years of age and to ...
DOI:: 10.1016/j.vaccine.2018.12.075
: https://dx.doi.org/10.1016/j.vaccine.2018.12.075

6. Trends in U.S. Community hospitalizations due to herpes zoster: 2001–2015

Author:: Pham, Matthew A.; Bednarczyk, Robert A.; Becker, Edmund R.; Orenstein, Walter A.; Omer, Saad B.
Source:: Vaccine 2019 v.37 no.6 pp. 882-888
ISSN:: 0264-410X
Subject:: United States, etc ; Human alphaherpesvirus 3; hospitals; vaccines; children; vaccination; people; issues and policy; adults; Show all 9 Subjects
Abstract:: ... In 2007, based on decisions by the U.S. Advisory Committee on Immunization Practices, the CDC recommended a booster dose at 4–6 years in the varicella vaccine schedule. In 2008, a herpes zoster vaccine was recommended for use in persons age ≥60 years. The purpose of this study was to examine trends in herpes zoster hospitalization rates and assess the impact of both policy recommendations using U. ...
DOI:: 10.1016/j.vaccine.2018.12.034
: https://dx.doi.org/10.1016/j.vaccine.2018.12.034

7. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008–2016)

Author:: Hirth, Jacqueline M.; Fuchs, Erika L.; Chang, Mihyun; Fernandez, Maria E.; Berenson, Abbey B.
Source:: Vaccine 2019 v.37 no.4 pp. 595-601
ISSN:: 0264-410X
Subject:: United States, etc ; Papillomaviridae; adolescents; advocacy; children; fearfulness; nationalities and ethnic groups; neoplasms; parents; surveys; vaccination; vaccines; Show all 12 Subjects
Abstract:: ... Human papillomavirus (HPV) vaccination is expected to reduce HPV-related disease and cancer in the US. However, many parents are hesitant to obtain the vaccine for their children. The purpose of this study is to examine how the reasons for refusing the HPV vaccine vary across regions of the US, across time, and by race/ethnicity.This study used data on 13–17 year old adolescents collected by the N ...
DOI:: 10.1016/j.vaccine.2018.12.017
: https://dx.doi.org/10.1016/j.vaccine.2018.12.017

8. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14–26 year old females in the U.S.

Author:: Hirth, Jacqueline; McGrath, Christine J.; Kuo, Yong-Fang; Rupp, Richard E.; Starkey, Jonathan M.; Berenson, Abbey B.
Source:: Vaccine 2018 v.36 no.50 pp. 7682-7688
ISSN:: 0264-410X
Subject:: United States, etc ; Mexican Americans; National Health and Nutrition Examination Survey; Papillomaviridae; adolescents; children; females; income; minorities (people); models; retrospective studies; vaccination; vaccines; Show all 13 Subjects
Abstract:: ... Low human papillomavirus (HPV) vaccination rates early after introduction, particularly among low income and minority adolescents, may have resulted in disparities in vaccine-type HPV prevalence (types 6, 11, 16, 18). The purpose of this study was to examine racial/ethnic variations in HPV prevalence, and evaluate how HPV vaccination has affected vaccine-type HPV prevalence across time.This study ...
DOI:: 10.1016/j.vaccine.2018.10.075
: https://dx.doi.org/10.1016/j.vaccine.2018.10.075

9. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012–2016

Author:: Walker, William L.; Hills, Susan L.; Miller, Elaine R.; Fischer, Marc; Rabe, Ingrid B.
Source:: Vaccine 2018 v.36 no.29 pp. 4369-4374
ISSN:: 0264-410X
Subject:: United States, etc ; anaphylaxis; children; encephalitis; monitoring; people; seizures; vaccination; vaccines; Show all 9 Subjects
Abstract:: ... In March 2009, the U.S. Food and Drug Administration licensed an inactivated Vero cell culture-derived Japanese encephalitis vaccine (JE-VC [IXIARO®]) for use in persons aged ≥17 years. In 2013, licensure was extended to include children aged ≥2 months. A previous analysis reviewed adverse events reported to the U.S. Vaccine Adverse Event Reporting System (VAERS) from May 2009 through April 2012.W ...
DOI:: 10.1016/j.vaccine.2018.04.038
: https://dx.doi.org/10.1016/j.vaccine.2018.04.038

10. Examination of universal purchase programs as a driver of vaccine uptake among US States, 1995–2014

Author:: Mulligan, Karen; Snider, Julia Thornton; Arthur, Phyllis; Frank, Gregory; Tebeka, Mahlet; Walker, Amy; Abrevaya, Jason
Source:: Vaccine 2018 v.36 no.28 pp. 4032-4038
ISSN:: 0264-410X
Subject:: United States, etc ; children; demography; issues and policy; prices; public health; purchasing; regression analysis; surveys; vaccination; vaccines; Show all 11 Subjects
Abstract:: ... Immunization against numerous potentially life-threatening illnesses has been a great public health achievement. In the United States, the Vaccines for Children (VFC) program has provided vaccines to uninsured and underinsured children since the early 1990s, increasing vaccination rates. In recent years, some states have adopted Universal Purchase (UP) programs with the stated aim of further incre ...
DOI:: 10.1016/j.vaccine.2018.05.103
: https://dx.doi.org/10.1016/j.vaccine.2018.05.103

11. An innovative medical school curriculum to address human papillomavirus vaccine hesitancy

Author:: Schnaith, Abigail M.; Evans, Erica M.; Vogt, Caleb; Tinsay, Andrea M.; Schmidt, Thomas E.; Tessier, Katelyn M.; Erickson, Britt K.
Source:: Vaccine 2018 v.36 no.26 pp. 3830-3835
ISSN:: 0264-410X
Subject:: United States, etc ; Papillomaviridae; children; curriculum; epidemiology; females; males; medical education; morbidity; parents; physicians; students; surveys; vaccination; vaccines; Show all 15 Subjects
Abstract:: ... Vaccination rates against Human Papillomavirus (HPV) in the US remain alarmingly low. Physicians can significantly influence a parent’s decision to vaccinate their children. However, medical education often lacks training on specific strategies for communicating with vaccine hesitant parents.We created an innovative curriculum designed to teach medical students how to address HPV vaccine hesitancy ...
DOI:: 10.1016/j.vaccine.2018.05.014
: https://dx.doi.org/10.1016/j.vaccine.2018.05.014

12. Pharmacies versus doctors’ offices for adolescent vaccination

Author:: Shah, Parth D.; Marciniak, Macary W.; Golden, Shelley D.; Trogdon, Justin G.; Golin, Carol E.; Brewer, Noel T.
Source:: Vaccine 2018 v.36 no.24 pp. 3453-3459
ISSN:: 0264-410X
Subject:: United States, etc ; adolescents; children; health services; hospitals; parents; patients; physicians; surveys; vaccination; vaccines; Show all 11 Subjects
Abstract:: ... We sought to understand the relative advantage of pharmacies compared to doctors’ offices for delivering HPV vaccination to adolescents.Participants were a national sample of 1500 U.S. parents of adolescents ages 11–17 recruited in 2014–15. In an online survey, items informed by Diffusion of Innovation Theory assessed parents’ perceptions of the relative advantages of HPV vaccine delivery in pharm ...
DOI:: 10.1016/j.vaccine.2018.04.088
: https://dx.doi.org/10.1016/j.vaccine.2018.04.088

13. “When you are injected, the baby is protected:” Assessing the acceptability of a maternal Tdap vaccine based on mothers’ knowledge, attitudes, and beliefs of pertussis and vaccinations in Lusaka, Zambia

Author:: Larson Williams, Anna; McCloskey, Lois; Mwale, Magdalene; Mwananyanda, Lawrence; Murray, Kenya; Herman, Augusta R.; Thea, Donald M.; MacLeod, William B.; Gill, Christopher J.
Source:: Vaccine 2018 v.36 no.21 pp. 3048-3053
ISSN:: 0264-410X
Subject:: United States, etc ; attitudes and opinions; children; clinical trials; cohort studies; decision making; focus groups; health services; infants; mothers; pregnant women; public health; vaccination; vaccines; United Kingdom; Zambia; Show all 16 Subjects
Abstract:: ... Severe and fatal pertussis infections are concentrated among infants who are too young to be protected through routine vaccinations. Maternal Tdap (mTdap), which is now the standard of care in the US and UK, is considered to be the most effective way to address this gap in preventative care. Little is known about how pregnant women in low-resource settings might view mTdap. To inform strategies fo ...
DOI:: 10.1016/j.vaccine.2018.03.081
: https://dx.doi.org/10.1016/j.vaccine.2018.03.081

14. Vaccine delivery to newly arrived refugees and estimated costs in selected U.S. clinics, 2015

Author:: Pezzi, Clelia; McCulloch, Audrey; Joo, Heesoo; Cochran, Jennifer; Smock, Laura; Frerich, Ellen; Mamo, Blain; Urban, Kailey; Hughes, Stephen; Payton, Colleen; Scott, Kevin; Maskery, Brian; Lee, Deborah
Source:: Vaccine 2018 v.36 no.20 pp. 2902-2909
ISSN:: 0264-410X
Subject:: United States, etc ; children; cost effectiveness; cost estimates; educational institutions; refugees; vaccination; vaccines; Show all 8 Subjects
Abstract:: ... Newly arrived refugees are offered vaccinations during domestic medical examinations. Vaccination practices and costs for refugees have not been described with recent implementation of the overseas Vaccination Program for U.S.-bound Refugees (VPR). We describe refugee vaccination during the domestic medical examination and the estimated vaccination costs from the US government perspective in selec ...
DOI:: 10.1016/j.vaccine.2017.12.023
: http://dx.doi.org/10.1016/j.vaccine.2017.12.023

15. Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older

Author:: Nishikawa, Alvaro Mitsunori; Sartori, Ana Marli Christovam; Mainardi, Giulia Marcelino; Freitas, Angela Carvalho; Itria, Alexander; Novaes, Hillegonda Maria Dutilh; de Soárez, Patrícia Coelho
Source:: Vaccine 2018 v.36 no.19 pp. 2510-2522
ISSN:: 0264-410X
Subject:: United States, etc ; adults; childhood; children; cost effectiveness; decision making; economic evaluation; medicine; models; polysaccharides; quality-adjusted life year; systematic review; uncertainty; vaccination; vaccines; Brazil; Colombia; Europe; Latin America; Show all 19 Subjects
Abstract:: ... To systematically review the economic evaluations of 23-valent pneumococcal polysaccharide vaccine (PPV23) in adults aged ≥60 years to inform the development of local studies through the discussion of parameters and assumptions that influence the results of the analyses.We searched the MEDLINE, Excerpta Medica, Cochrane Library, Latin-American and Caribbean Health Sciences Literature (LILACS), Bra ...
DOI:: 10.1016/j.vaccine.2018.03.070
: http://dx.doi.org/10.1016/j.vaccine.2018.03.070

16. Vaccination coverage among foreign-born and U.S.-born adolescents in the United States: Successes and gaps – National Immunization Survey-Teen, 2012–2014

Author:: Healy, Jessica; Rodriguez-Lainz, Alfonso; Elam-Evans, Laurie D.; Hill, Holly A.; Reagan-Steiner, Sarah; Yankey, David
Source:: Vaccine 2018 v.36 no.13 pp. 1743-1750
ISSN:: 0264-410X
Subject:: United States, etc ; Papillomaviridae; adolescents; adults; caregivers; childhood; children; education; hepatitis B; humans; insurance; males; measles; socioeconomic factors; surveys; telephones; tetanus; toxoids; vaccination; vaccines; Show all 20 Subjects
Abstract:: ... An overall increase has been reported in vaccination rates among adolescents during the past decade. Studies of vaccination coverage have shown disparities when comparing foreign-born and U.S.-born populations among children and adults; however, limited information is available concerning potential disparities in adolescents.The National Immunization Survey-Teen is a random-digit–dialed telephone ...
DOI:: 10.1016/j.vaccine.2018.02.052
: https://dx.doi.org/10.1016/j.vaccine.2018.02.052

17. Hepatitis A vaccination coverage among adolescents (13–17 years) in the United States, 2008–2016

Author:: Nelson, Noele P.; Yankey, David; Singleton, James A.; Elam-Evans, Laurie D.
Source:: Vaccine 2018 v.36 no.12 pp. 1650-1659
ISSN:: 0264-410X
Subject:: United States, etc ; immunity; Hispanics; risk; poverty; hepatitis A; Hepatovirus A; vaccines; vaccination; children; adolescents; rural areas; Show all 12 Subjects
Abstract:: ... The hepatitis A (HepA) vaccine was recommended by the Advisory Committee on Immunization Practices (ACIP) incrementally from 1996 to 1999. In 2006, HepA vaccine was recommended (1) universally for children aged 12–23 months, (2) for persons who are at increased risk for infection, or (3) for any person wishing to obtain immunity. Catch-up vaccination can be considered.To assess HepA vaccine covera ...
DOI:: 10.1016/j.vaccine.2018.01.090
: https://dx.doi.org/10.1016/j.vaccine.2018.01.090

18. Parent perceptions of dentists’ role in HPV vaccination

Author:: Lazalde, Gabriela E.; Gilkey, Melissa B.; Kornides, Melanie L.; McRee, Annie-Laurie
Source:: Vaccine 2018 v.36 no.4 pp. 461-466
ISSN:: 0264-410X
Subject:: United States, etc ; adolescents; attitudes and opinions; children; dentists; females; health care workers; insurance; males; oral health; parents; surveys; vaccination; vaccines; Show all 14 Subjects
Abstract:: ... Offering HPV vaccine in settings beyond the traditional medical home holds promise for increasing the currently low levels of coverage. As adolescents frequently visit dentists, dental practices may be one such alternative vaccination setting. This study assessed parent attitudes about the roles dental providers could play in HPV prevention, including vaccine provision.In September 2016, we conduc ...
DOI:: 10.1016/j.vaccine.2017.12.020
: http://dx.doi.org/10.1016/j.vaccine.2017.12.020

19. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015

Author:: Haber, Penina; Moro, Pedro L.; Ng, Carmen; Lewis, Paige W.; Hibbs, Beth; Schillie, Sarah F.; Nelson, Noele P.; Li, Rongxia; Stewart, Brock; Cano, Maria V.
Source:: Vaccine 2018 v.36 no.4 pp. 559-564
ISSN:: 0264-410X
Subject:: United States, etc ; Bayesian theory; adults; blood; children; death; education; erythema; fever; hepatitis B; hepatitis B antigens; infants; injection site; nausea; nervous system diseases; people; vaccination; vaccines; Show all 18 Subjects
Abstract:: ... Currently four recombinant hepatitis B (HepB) vaccines are in use in the United States. HepB vaccines are recommended for infants, children and adults. We assessed adverse events (AEs) following HepB vaccines reported to the Vaccine Adverse Event Reporting System (VAERS), a national spontaneous reporting system.We searched VAERS for reports of AEs following single antigen HepB vaccine and HepB-con ...
DOI:: 10.1016/j.vaccine.2017.11.079
: http://dx.doi.org/10.1016/j.vaccine.2017.11.079

20. Public health impact of Rotarix vaccination among commercially insured children in the United States

Author:: Krishnarajah, Girishanthy; Kageleiry, Andrew; Korves, Caroline; Lefebvre, Patrick; Duh, Mei S.
Source:: Vaccine 2017 v.35 no.37 pp. 5065-5072
ISSN:: 0264-410X
Subject:: United States, etc ; Rotavirus; children; confidence interval; databases; diarrhea; equations; gender; health care costs; public health; vaccination; Show all 11 Subjects
Abstract:: ... This study (NCT01915888) assessed public health impact of Rotarix, GSK [RV1] vaccination.Children born between 2007–2011 were identified from Truven Commercial Claims and Encounters Databases and observed until earlier of plan disenrollment or five years old. Children receiving one or two doses of RV1 during the vaccination window were assigned to incomplete and complete vaccination cohorts, respe ...
DOI:: 10.1016/j.vaccine.2017.06.034
: https://dx.doi.org/10.1016/j.vaccine.2017.06.034

21. Semantic network analysis of vaccine sentiment in online social media

Author:: Kang, Gloria J.; Ewing-Nelson, Sinclair R.; Mackey, Lauren; Schlitt, James T.; Marathe, Achla; Abbas, Kaja M.; Swarup, Samarth
Source:: Vaccine 2017 v.35 no.29 pp. 3621-3638
ISSN:: 0264-410X
Subject:: United States, etc ; Internet; attitudes and opinions; autism; children; disease outbreaks; parents; pharmaceutical industry; physicians; public health; risk; social networks; vaccination; vaccines; Show all 14 Subjects
Abstract:: ... To examine current vaccine sentiment on social media by constructing and analyzing semantic networks of vaccine information from highly shared websites of Twitter users in the United States; and to assist public health communication of vaccines.Vaccine hesitancy continues to contribute to suboptimal vaccination coverage in the United States, posing significant risk of disease outbreaks, yet remain ...
DOI:: 10.1016/j.vaccine.2017.05.052
PubMed:: 28554500
PubMed Central:: PMC5548132
: https://dx.doi.org/10.1016/j.vaccine.2017.05.052

22. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants

Author:: Klein, Nicola P.; Abu-Elyazeed, Remon; Cornish, Matthew; Leonardi, Michael L.; Weiner, Leonard B.; Silas, Peter E.; Grogg, Stanley E.; Varman, Meera; Frenck, Robert W.; Cheuvart, Brigitte; Baine, Yaela; Miller, Jacqueline M.; Leyssen, Maarten; Mesaros, Narcisa; Roy-Ghanta, Sumita
Source:: Vaccine 2017 v.35 no.28 pp. 3564-3574
ISSN:: 0264-410X
Subject:: United States, etc ; Haemophilus influenzae; antibodies; antigens; children; immune response; infants; secondary immunization; tetanus; vaccination; vaccines; Show all 11 Subjects
Abstract:: ... Vaccination against Haemophilus influenzae type b (Hib) is included in routine pediatric immunization schedule in the United States. Previous vaccine shortages have created the need for additional options for Hib vaccination.This phase III, randomized, multi-centered study (NCT01000974) evaluated the safety and immunogenicity of a monovalent tetanus toxoid-conjugate Hib vaccine (Hib-TT) compared t ...
DOI:: 10.1016/j.vaccine.2017.05.018
: https://dx.doi.org/10.1016/j.vaccine.2017.05.018

23. Missed opportunities for simultaneous administration of the fourth dose of DTaP among children in the United States

Author:: Zhao, Zhen; Smith, Philip J.; Hill, Holly A.
Source:: Vaccine 2017 v.35 no.24 pp. 3191-3195
ISSN:: 0264-410X
Subject:: United States, etc ; children; people; risk factors; surveys; tetanus; toxoids; vaccination; vaccines; Show all 9 Subjects
Abstract:: ... Simultaneous administration of all age-appropriate doses of vaccines is an effective strategy for raising vaccination coverage. Vaccination coverage for ≥4 dose of DTaP (diphtheria, tetanus toxoids, and acellular pertussis vaccine) among children 19–35months in the United States has not reached the Healthy People 2020 target of 90%. Risk factors for missed opportunities for simultaneous administra ...
DOI:: 10.1016/j.vaccine.2017.04.070
: https://dx.doi.org/10.1016/j.vaccine.2017.04.070

24. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014–2015 season

Author:: McLean, Huong Q.; Caspard, Herve; Griffin, Marie R.; Poehling, Katherine A.; Gaglani, Manjusha; Belongia, Edward A.; Talbot, H. Keipp; Peters, Timothy R.; Murthy, Kempapura; Ambrose, Christopher S.
Source:: Vaccine 2017 v.35 no.20 pp. 2685-2693
ISSN:: 0264-410X
Subject:: United States, etc ; influenza vaccines; nose; Influenza A virus; reverse transcriptase polymerase chain reaction; odds ratio; confidence interval; transcription (genetics); children; viruses; vaccination; influenza; Show all 12 Subjects
Abstract:: ... A clinical study found that live attenuated influenza vaccine (LAIV) was superior to inactivated influenza vaccine (IIV) against drifted A(H3N2) viruses in children. During the 2014–2015 influenza season, widespread circulation of antigenically and genetically drifted A(H3N2) viruses provided an opportunity to evaluate subtype-specific vaccine effectiveness (VE) of quadrivalent LAIV (LAIV4) and II ...
DOI:: 10.1016/j.vaccine.2017.03.085
: https://dx.doi.org/10.1016/j.vaccine.2017.03.085

25. Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010–2012

Author:: Millman, Alexander J.; Reynolds, Sue; Duffy, Jonathan; Chen, Jufu; Gargiullo, Paul; Fry, Alicia M.
Source:: Vaccine 2017 v.35 no.4 pp. 529-535
ISSN:: 0264-410X
Subject:: United States, etc ; risk; at-risk population; vaccines; regression analysis; children; asthma; vaccination; influenza; clinical trials; databases; Show all 11 Subjects
Abstract:: ... Live attenuated influenza vaccine (LAIV) is safe in healthy children ⩾2years. The original clinical trials excluded individuals with underlying conditions; however, post-marketing data suggest LAIV may be safe for these populations.We analyzed MarketScan Commercial Claims Databases from 2010 to 2012 to describe hospitalizations within 14days of vaccination among LAIV recipients. We evaluated LAIV ...
DOI:: 10.1016/j.vaccine.2016.12.033
PubMed:: 28041779
PubMed Central:: PMC5949885
: https://dx.doi.org/10.1016/j.vaccine.2016.12.033

26. Vaccine strategies: Optimising outcomes

Author:: Hardt, Karin; Bonanni, Paolo; King, Susan; Santos, Jose Ignacio; El-Hodhod, Mostafa; Zimet, Gregory D.; Preiss, Scott
Source:: Vaccine 2016 v.34 no.52 pp. 6691-6699
ISSN:: 0264-410X
Subject:: United States, etc ; Papillomaviridae; World Health Organization; childhood; children; developing countries; funding; health services; hepatitis B; humans; income; infrastructure; monitoring; vaccination; vaccines; Australia; South America; United Kingdom; Show all 18 Subjects
Abstract:: ... Successful immunisation programmes generally result from high vaccine effectiveness and adequate uptake of vaccines. In the development of new vaccination strategies, the structure and strength of the local healthcare system is a key consideration. In high income countries, existing infrastructures are usually used, while in less developed countries, the capacity for introducing new vaccines may n ...
DOI:: 10.1016/j.vaccine.2016.10.078
: https://dx.doi.org/10.1016/j.vaccine.2016.10.078

27. Uptake of rotavirus vaccine among US infants at Immunization Information System Sentinel Sites

Author:: Pringle, Kimberly; Cardemil, Cristina V.; Pabst, Laura J.; Parashar, Umesh D.; Cortese, Margaret M.
Source:: Vaccine 2016 v.34 no.50 pp. 6396-6401
ISSN:: 0264-410X
Subject:: United States, etc ; Rotavirus; childhood; children; infancy; infants; information systems; tetanus; vaccination; vaccines; Show all 10 Subjects
Abstract:: ... Coverage with rotavirus vaccine among US children has been lower compared to that with other routine childhood vaccines. Our objectives were to examine rotavirus vaccine (RV) uptake over time compared to other routine vaccinations, ages at administration, and quantitate potential missed opportunities for RV receipt.We analyzed data from 6 Immunization Information System (IIS) Sentinel Sites, which ...
DOI:: 10.1016/j.vaccine.2016.10.005
: https://dx.doi.org/10.1016/j.vaccine.2016.10.005

28. Parental experiences with vaccine information statements: Implications for timing, delivery, and parent-provider immunization communication

Author:: Frew, Paula M.; Chung, Yunmi; Fisher, Allison Kennedy; Schamel, Jay; Basket, Michelle M.
Source:: Vaccine 2016 v.34 no.48 pp. 5840-5844
ISSN:: 0264-410X
Subject:: United States, etc ; children; guidelines; parents; reading; surveys; vaccination; vaccines; Show all 8 Subjects
Abstract:: ... We examined Vaccine Information Statements (VIS) dissemination practices and parental use and perceptions.We conducted a national online panel survey of 2603 US parents of children aged <7. Primary outcomes included reported VIS receipt, delivery timing, reading experiences, and perceived utility.Most parents received a VIS (77.2%; [95% CI: 74.5–79.7%]), 59.7% [56.6–62.7%] before vaccination but 1 ...
DOI:: 10.1016/j.vaccine.2016.10.026
: https://dx.doi.org/10.1016/j.vaccine.2016.10.026

29. Trends in childhood vaccine purchase costs in the US public sector: 1996–2014

Author:: Chen, Weiwei; Messonnier, Mark; Zhou, Fangjun
Source:: Vaccine 2016 v.34 no.39 pp. 4706-4711
ISSN:: 0264-410X
Subject:: United States, etc ; childhood; children; cost effectiveness; prices; public sector; vaccination; vaccines; Show all 8 Subjects
Abstract:: ... While vaccination remains as one of the most cost-effective preventive strategies, the cost of fully immunizing a child has grown considerably over the last few decades. This study examines trends in non-influenza childhood vaccine purchase costs in the public sector from 1996 to 2014. Non-influenza vaccine purchase cost per child for children aged 0 through 18years was calculated based on public- ...
DOI:: 10.1016/j.vaccine.2016.08.012
: https://dx.doi.org/10.1016/j.vaccine.2016.08.012

30. Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children

Author:: Hankin-Wei, Abigail; Rein, David B.; Hernandez-Romieu, Alfonso; Kennedy, Mallory J.; Bulkow, Lisa; Rosenberg, Eli; Trigg, Monica; Nelson, Noele P.
Source:: Vaccine 2016 v.34 no.35 pp. 4243-4249
ISSN:: 0264-410X
Subject:: United States, etc ; cost effectiveness; death; quality-adjusted life year; hepatitis A; Hepatovirus A; economic costs; vaccines; children; econometric models; vaccination; biological resistance; Markov chain; disease incidence; Show all 14 Subjects
Abstract:: ... Since 2006, the US Centers for Disease Control and Prevention has recommended hepatitis A (HepA) vaccination routinely for children aged 12–23months to prevent hepatitis A virus (HAV) infection. However, a substantial proportion of US children are unvaccinated and susceptible to infection. We present results of economic modeling to assess whether a one-time catch-up HepA vaccination recommendation ...
DOI:: 10.1016/j.vaccine.2016.06.040
PubMed:: 27317459
PubMed Central:: PMC5582969
: https://dx.doi.org/10.1016/j.vaccine.2016.06.040

31. Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers

Author:: Hansen, John; Timbol, Julius; Lewis, Ned; Pool, Vitali; Decker, Michael D.; Greenberg, David P.; Klein, Nicola P.
Source:: Vaccine 2016 v.34 no.35 pp. 4172-4179
ISSN:: 0264-410X
Subject:: United States, etc ; children; consciousness; encephalitis; encephalopathy; hemolytic anemia; hypersensitivity; infants; insulin-dependent diabetes mellitus; meningitis; retrospective studies; risk; seizures; thrombocytopenic purpura; toddlers; vaccination; vaccines; Show all 17 Subjects
Abstract:: ... The combination DTaP-IPV/Hib vaccine was licensed in the United States in 2008 for children ages 6weeks through 4years with doses administered at 2, 4, 6, and 15–18months of age. The aim of this study was to assess the safety of DTaP-IPV/Hib vaccine routinely administered as part of clinical care to infants at Kaiser Permanente Northern California.This was an observational, retrospective study tha ...
DOI:: 10.1016/j.vaccine.2016.06.062
: https://dx.doi.org/10.1016/j.vaccine.2016.06.062

32. Hurdles to herd immunity: Distrust of government and vaccine refusal in the US, 2002–2003

Author:: Lee, Charlotte; Whetten, Kathryn; Omer, Saad; Pan, William; Salmon, Daniel
Source:: Vaccine 2016 v.34 no.34 pp. 3972-3978
ISSN:: 0264-410X
Subject:: United States, etc ; alternative medicine; childhood; children; health care workers; herd immunity; information sources; parents; public health; surveys; vaccination; vaccines; Show all 12 Subjects
Abstract:: ... High rates of nonmedical exemptions (NMEs) from required childhood vaccinations have contributed to outbreaks of vaccine-preventable diseases, such as measles and pertussis. Understanding the parental decision to obtain an NME could help health professionals and public health programs improve vaccination rates in areas with high vaccine refusal. Using a 2002–2003 multi-state survey of parents of s ...
DOI:: 10.1016/j.vaccine.2016.06.048
: https://dx.doi.org/10.1016/j.vaccine.2016.06.048

33. Evaluation of potentially achievable vaccination coverage with simultaneous administration of vaccines among children in the United States

Author:: Zhao, Zhen; Smith, Philip J.; Hill, Holly A.
Source:: Vaccine 2016 v.34 no.27 pp. 3030-3036
ISSN:: 0264-410X
Subject:: United States, etc ; Haemophilus influenzae; childhood; children; people; tetanus; toxoids; vaccination; vaccines; Show all 9 Subjects
Abstract:: ... Routine administration of all age-appropriate doses of vaccines during the same visit is recommended for children by the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).Evaluate the potentially achievable vaccination coverage for ≥4 doses of diphtheria and tetanus toxoids and acellular pertussis vaccine (4+DTaP), ≥4 doses of pneumococcal conju ...
DOI:: 10.1016/j.vaccine.2016.04.097
: https://dx.doi.org/10.1016/j.vaccine.2016.04.097

34. Reasons given for not receiving an influenza vaccination, 2011–12 influenza season, United States

Author:: Santibanez, Tammy A.; Kennedy, Erin D.
Source:: Vaccine 2016 v.34 no.24 pp. 2671-2678
ISSN:: 0264-410X
Subject:: United States, etc ; Blacks; Hispanics; Whites; adults; adverse effects; chi-square distribution; children; ethnic differences; gender; income; influenza; models; parents; races; regression analysis; surveys; vaccination; vaccines; Show all 19 Subjects
Abstract:: ... Influenza vaccination coverage in the United States remains below national targets and racial/ethnic differences persist.To gain insights into potential strategies for improving influenza vaccination by examining reasons given for not receiving an influenza vaccination during the 2011–12 influenza season.Data from the National Flu Survey were analyzed for the 2011–12 influenza season.Tests of asso ...
DOI:: 10.1016/j.vaccine.2016.04.039
PubMed:: 27118168
PubMed Central:: PMC5751433
: https://dx.doi.org/10.1016/j.vaccine.2016.04.039

35. Challenges to health workers and their opinions about parents’ refusal of oral polio vaccination in the Khyber Pakhtoon Khawa (KPK) province, Pakistan

Author:: Khan, Tahir Mehmood; Sahibzada, Muhammad Umar Khayam
Source:: Vaccine 2016 v.34 no.18 pp. 2074-2081
ISSN:: 0264-410X
Subject:: United States, etc ; Muslims; adverse effects; attitudes and opinions; blood; children; education; experimental design; fever; health care workers; monkeys; parents; swine; vaccination; vaccines; Pakistan; Show all 16 Subjects
Abstract:: ... A qualitative study design was adapted to explore the challenges faced by health workers (HWs) during the polio health campaign. In addition, HWs’ opinions about the factors causing parents to refuse oral polio vaccination (OPV) were also explored. Four focus group discussions (FGDs) were held (from 1st January 2015–31st March 2015) with the HWs who participated in the OPV campaigns in the polio r ...
DOI:: 10.1016/j.vaccine.2016.03.008
: https://dx.doi.org/10.1016/j.vaccine.2016.03.008

36. Epidemiology of rubella and congenital rubella syndrome in Japan before 1989

Author:: Ueda, Kohji
Source:: Vaccine 2016 v.34 no.16 pp. 1971-1974
ISSN:: 0264-410X
Subject:: United States, etc ; serological surveys; schools; girls; hospitals; pregnant women; vaccines; males; high school students; disease outbreaks; children; teratogenicity; vaccination; Rubella virus; military lands; adults; Ryukyu Archipelago; Show all 17 Subjects
Abstract:: ... Epidemiological studies of rubella and congenital rubella syndrome (CRS) in Japan have been conducted since the first nationwide rubella epidemic of 1965–1969 and subsequent epidemics of 1975–1977, 1982, 1987–1988, and 1992–1993. Rubella was non-endemic in Japan before the 1975–1977 epidemic, and endemic thereafter. Japan started a selective rubella vaccination program for junior high school girls ...
DOI:: 10.1016/j.vaccine.2015.10.010
: https://dx.doi.org/10.1016/j.vaccine.2015.10.010

37. Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease

Author:: Watson, Philip S.; Turner, David P.J.
Source:: Vaccine 2016 v.34 no.7 pp. 875-880
ISSN:: 0264-410X
Subject:: United States, etc ; European Union; children; clinical trials; college students; disease incidence; industrialization; infants; morbidity; mortality; serotypes; vaccination; vaccines; young adults; Australia; Brazil; Chile; Italy; Quebec; United Kingdom; Uruguay; Show all 21 Subjects
Abstract:: ... Although rare, invasive meningococcal disease remains an important cause of mortality and morbidity in children and young adults. Vaccines have been successfully introduced to help protect against meningococcal disease caused by serogroups A, C, W and Y, but until recently, a vaccine for serogroup B (MenB) was not available. In many industrialised countries, MenB causes the majority of meningococc ...
DOI:: 10.1016/j.vaccine.2015.11.057
: https://dx.doi.org/10.1016/j.vaccine.2015.11.057

38. Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996–2011

Author:: Chang, D.H.; Bednarczyk, Robert A.; Becker, Edmund R.; Hockenberry, Jason M.; Weiss, Paul S.; Orenstein, Walter A.; Omer, Saad B.
Source:: Vaccine 2016 v.34 no.4 pp. 486-494
ISSN:: 0264-410X
Subject:: United States, etc ; children; death; influenza; issues and policy; morbidity; mortality; people; pneumonia; sepsis (infection); time series analysis; vaccination; vaccines; Show all 13 Subjects
Abstract:: ... To reduce excess morbidity and mortality of pneumonia and influenza (PI), the Advisory Committee on Immunization Practices has recommended the use of 7-valent pneumococcal conjugate vaccine (PCV7), and incrementally expanded the target group for annual influenza vaccination of healthy persons, to ultimately include all persons ≥6 months of age without contraindications as of the 2010–2011 influenz ...
DOI:: 10.1016/j.vaccine.2015.12.003
: https://dx.doi.org/10.1016/j.vaccine.2015.12.003

39. Completion and compliance of childhood vaccinations in the United States

Author:: Kurosky, Samantha K.; Davis, Keith L.; Krishnarajah, Girishanthy
Source:: Vaccine 2016 v.34 no.3 pp. 387-394
ISSN:: 0264-410X
Subject:: United States, etc ; antigens; childhood; children; compliance; issues and policy; people; surveys; vaccination; vaccines; Show all 10 Subjects
Abstract:: ... The Advisory Committee on Immunization Practices recommends routine childhood vaccination by age 2 years, yet evidence suggests that only 2% to 26% of children receive vaccine doses at age-appropriate times (compliance). The objective of this study was to estimate vaccine completion and compliance rates between birth and age 2 years using recent, nationally representative data.Using a sample of ch ...
DOI:: 10.1016/j.vaccine.2015.11.011
: https://dx.doi.org/10.1016/j.vaccine.2015.11.011

40. Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010–13, United States

Author:: Cowling, Benjamin J.; Feng, Shuo; Finelli, Lyn; Steffens, Andrea; Fowlkes, Ashley
Source:: Vaccine 2016 v.34 no.1 pp. 61-66
ISSN:: 0264-410X
Subject:: United States, etc ; Influenza A virus; children; disease outbreaks; elderly; influenza; laboratory experimentation; monitoring; odds ratio; patients; vaccination; vaccines; Show all 12 Subjects
Abstract:: ... Influenza vaccines are now widely used to reduce the burden of annual epidemics of influenza virus infections. Influenza vaccine effectiveness (VE) is monitored annually to determine VE against each season's circulating influenza strains in different groups such as children, adults and the elderly. Few prospective surveillance programs are available to evaluate influenza VE against medically atten ...
DOI:: 10.1016/j.vaccine.2015.11.016
PubMed:: 26611200
PubMed Central:: PMC4889456
: https://dx.doi.org/10.1016/j.vaccine.2015.11.016

41. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2–17 years of age in 2013–2014 in the United States

Author:: Caspard, Herve; Gaglani, Manjusha; Clipper, Lydia; Belongia, Edward A.; McLean, Huong Q.; Griffin, Marie R.; Talbot, H. Keipp; Poehling, Katherine A.; Peters, Timothy R.; Veney, Naomi; Ambrose, Christopher S.
Source:: Vaccine 2016 v.34 no.1 pp. 77-82
ISSN:: 0264-410X
Subject:: United States, etc ; adolescents; children; heat stability; influenza; nose; observational studies; odds ratio; reverse transcriptase polymerase chain reaction; vaccination; vaccines; Show all 11 Subjects
Abstract:: ... A postmarketing observational study was initiated to evaluate quadrivalent live attenuated influenza vaccine (LAIV) effectiveness in children aged 2–17 years in the United States.Children and adolescents aged 2–17 years seeking outpatient care for febrile acute respiratory illness <5 days duration were enrolled at 4 geographically diverse sites during the 2013–2014 influenza season. Nasal swabs we ...
DOI:: 10.1016/j.vaccine.2015.11.010
: https://dx.doi.org/10.1016/j.vaccine.2015.11.010

42. Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009

Author:: Weiss, Thomas; Zhang, Dongmu; Borse, Nagesh N.; Walter, Emmanuel B.
Source:: Vaccine 2015 v.33 no.48 pp. 6871-6877
ISSN:: 0264-410X
Subject:: United States, etc ; children; databases; health services; hepatitis A; observational studies; pediatricians; vaccination; vaccines; Show all 9 Subjects
Abstract:: ... To estimate hepatitis A vaccine series initiation and completion rates, assess time to vaccination, identify missed opportunities for the hepatitis A vaccine series, and examine factors associated with hepatitis A vaccine series initiation and completion.We conducted a retrospective, observational study using three healthcare claims databases separately. The study population was comprised of child ...
DOI:: 10.1016/j.vaccine.2015.07.065
: https://dx.doi.org/10.1016/j.vaccine.2015.07.065

43. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines

Author:: Pilishvili, Tamara; Bennett, Nancy M.
Source:: Vaccine 2015 v.33 pp. D60
ISSN:: 0264-410X
Subject:: United States, etc ; Streptococcus pneumoniae; bacterial pneumonia; burden of disease; children; disease prevention; elderly; issues and policy; morbidity; mortality; polysaccharides; vaccination; vaccines; Show all 13 Subjects
Abstract:: ... Use of the pneumococcal conjugate vaccines among children in the US since 2000 has dramatically reduced pneumococcal disease burden among adults. Significant vaccine-preventable morbidity and mortality from pneumococcal infections still remains, especially among older adults. The US Advisory Committee on Immunization Practices (ACIP) has recently recommended the routine use of both pneumococcal co ...
DOI:: 10.1016/j.vaccine.2015.05.102
: https://dx.doi.org/10.1016/j.vaccine.2015.05.102

44. Vaccine hesitancy

Author:: Salmon, Daniel A.; Dudley, Matthew Z.; Glanz, Jason M.; Omer, Saad B.
Source:: Vaccine 2015 v.33 pp. D66
ISSN:: 0264-410X
Subject:: United States, etc ; Haemophilus influenzae; children; corporations; parents; physicians; pregnant women; public health; risk communication; vaccination; vaccines; wastes; Show all 12 Subjects
Abstract:: ... Vaccine hesitancy reflects concerns about the decision to vaccinate oneself or one’s children. There is a broad range of factors contributing to vaccine hesitancy, including the compulsory nature of vaccines, their coincidental temporal relationships to adverse health outcomes, unfamiliarity with vaccine-preventable diseases, and lack of trust in corporations and public health agencies. Although v ...
DOI:: 10.1016/j.vaccine.2015.09.035
: https://dx.doi.org/10.1016/j.vaccine.2015.09.035

45. Maternal benefits of immunization during pregnancy

Author:: Swamy, Geeta K.; Beigi, Richard H.
Source:: Vaccine 2015 v.33 no.47 pp. 6436-6440
ISSN:: 0264-410X
Subject:: United States, etc ; Centers for Disease Control and Prevention; abortion (animals); adolescents; adults; children; congenital abnormalities; low birth weight; morbidity; mortality; neonates; passive immunity; pregnancy outcome; pregnant women; premature birth; risk factors; vaccination; vaccines; Show all 18 Subjects
Abstract:: ... The US Centers for Disease Control & Prevention currently recommend routine immunization to prevent 17 vaccine-preventable diseases that occur in infants, children, adolescents, or adults. Pregnant women are at particularly high risk for morbidity and mortality related to several vaccine-preventable diseases. Furthermore, such illnesses are also associated with adverse pregnancy outcomes such as s ...
DOI:: 10.1016/j.vaccine.2015.08.035
: https://dx.doi.org/10.1016/j.vaccine.2015.08.035

46. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons

Author:: Jackson, Michael L.; Jackson, Lisa A.; Kieke, Burney; McClure, David; Gaglani, Manjusha; Murthy, Kempapura; Malosh, Ryan; Monto, Arnold; Zimmerman, Richard K.; Foppa, Ivo M.; Flannery, Brendan; Thompson, Mark G.
Source:: Vaccine 2015 v.33 no.39 pp. 5181-5187
ISSN:: 0264-410X
Subject:: United States, etc ; adults; children; influenza; monitoring; people; vaccination; vaccines; Show all 8 Subjects
Abstract:: ... We estimated the burden of outpatient influenza and cases prevented by vaccination during the 2011/2012 and 2012/2013 influenza seasons using data from the United States Influenza Vaccine Effectiveness (US Flu VE) Network.We defined source populations of persons who could seek care for acute respiratory illness (ARI) at each of the five US Flu VE Network sites. We identified all members of the sou ...
DOI:: 10.1016/j.vaccine.2015.07.098
PubMed:: 26271827
PubMed Central:: PMC5843472
: https://dx.doi.org/10.1016/j.vaccine.2015.07.098

47. Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011−12 through 2013−14 influenza seasons

Author:: Kahn, Katherine E.; Santibanez, Tammy A.; Zhai, Yusheng; Singleton, James A.
Source:: Vaccine 2015 v.33 no.39 pp. 5196-5203
ISSN:: 0264-410X
Subject:: United States, etc ; Blacks; Whites; chi-square distribution; children; confidence interval; health policy; income; influenza; poverty; regression analysis; t-test; vaccination; vaccines; Show all 14 Subjects
Abstract:: ... Influenza vaccines available for children in the United States include inactivated influenza vaccine (IIV) and live, attenuated influenza vaccine (LAIV). Objectives of this study were to quantify proportions of IIV and LAIV received by vaccinated children, and examine associations between vaccine type received and demographic characteristics.National Immunization Survey-Flu (NIS-Flu) parental repo ...
DOI:: 10.1016/j.vaccine.2015.07.064
PubMed:: 26238724
PubMed Central:: PMC4597891
: https://dx.doi.org/10.1016/j.vaccine.2015.07.064

48. Estimating the herd immunity effect of rotavirus vaccine

Author:: Pollard, Suzanne L.; Malpica-Llanos, Tanya; Friberg, Ingrid K.; Fischer-Walker, Christa; Ashraf, Sania; Walker, Neff
Source:: Vaccine 2015 v.33 no.32 pp. 3795-3800
ISSN:: 0264-410X
Subject:: United States, etc ; children; death; diarrhea; gastroenteritis; herd immunity; herds; markets; meta-analysis; morbidity; mortality; vaccination; vaccines; Latin America; Show all 14 Subjects
Abstract:: ... Diarrhea is one of the leading causes of death in children under 5, and an estimated 39% of these deaths are attributable to rotavirus. Currently two live, oral rotavirus vaccines have been introduced on the market; however, the herd immunity effect associated with rotavirus vaccine has not yet been quantified. The purpose of this meta-analysis was to estimate the herd immunity effects associated ...
DOI:: 10.1016/j.vaccine.2015.06.064
: https://dx.doi.org/10.1016/j.vaccine.2015.06.064

49. Deaths following vaccination: What does the evidence show?

Author:: Miller, Elaine R.; Moro, Pedro L.; Cano, Maria; Shimabukuro, Tom T.
Source:: Vaccine 2015 v.33 no.29 pp. 3288-3292
ISSN:: 0264-410X
Subject:: United States, etc ; Internet; Variola virus; Yellow fever virus; adults; adverse effects; anaphylaxis; cardiomyopathy; case studies; children; death; eczema; encephalitis; influenza; live vaccines; monitoring; myocarditis; people; public health; risk; syncope; vaccination; Show all 22 Subjects
Abstract:: ... Vaccines are rigorously tested and monitored and are among the safest medical products we use. Millions of vaccinations are given to children and adults in the United States each year. Serious adverse reactions are rare. However, because of the high volume of use, coincidental adverse events including deaths, that are temporally associated with vaccination, do occur. When death occurs shortly foll ...
DOI:: 10.1016/j.vaccine.2015.05.023
PubMed:: 26004568
PubMed Central:: PMC4599698
: https://dx.doi.org/10.1016/j.vaccine.2015.05.023

50. Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents

Author:: Wolff, Greg; Bell, Michael; Escobar, James; Ruiz, Stefani
Source:: Vaccine 2015 v.33 no.28 pp. 3228-3233
ISSN:: 0264-410X
Subject:: United States, etc ; Centers for Disease Control and Prevention; case-control studies; children; compliance; confidence interval; disease prevalence; patients; vaccination; vaccines; Show all 10 Subjects
Abstract:: ... Pertussis vaccination compliance is critical for reduction in the prevalence of disease; however, the current acellular pertussis vaccine may not provide sufficient protection from infection. This study examined acellular pertussis vaccine effectiveness (VE) for Air Force dependents less than 12 years of age.We conducted a case-control study among Air Force pediatric dependents from 2011 to 2013, ...
DOI:: 10.1016/j.vaccine.2015.04.084
: https://dx.doi.org/10.1016/j.vaccine.2015.04.084

51. Effect of multiple, simultaneous vaccines on polio seroresponse and associated health outcomes

Author:: Broderick, Michael P.; Oberste, M. Steven; Moore, Deborah; Romero-Steiner, Sandra; Hansen, Christian J.; Faix, Dennis J.
Source:: Vaccine 2015 v.33 no.24 pp. 2842-2848
ISSN:: 0264-410X
Subject:: United States, etc ; blood serum; children; infants; seroconversion; vaccination; vaccines; Show all 7 Subjects
Abstract:: ... Administration of multiple simultaneous vaccines to infants, children, and military recruits is not uncommon. However, little research exists to examine associated serological and health effects, especially in adults.We retrospectively examined 416 paired serum specimens from U.S. military subjects who had received the inactivated polio vaccine (IPV) alone or in combination with either 1 other vac ...
DOI:: 10.1016/j.vaccine.2014.07.088
: https://dx.doi.org/10.1016/j.vaccine.2014.07.088

52. Immune overload: Parental attitudes toward combination and single antigen vaccines

Author:: Hulsey, Ella; Bland, Tami
Source:: Vaccine 2015 v.33 no.22 pp. 2546-2550
ISSN:: 0264-410X
Subject:: United States, etc ; antigens; attitudes and opinions; children; decision making; fearfulness; immune system; parents; psychological stress; secondary infection; vaccination; vaccines; Show all 12 Subjects
Abstract:: ... Parental concerns have led to a recent decline in immunization coverage, resulting in outbreaks of diseases that were once under control in the US. As the CDC vaccination schedule continues to increase in complexity, the number of required injections per office visit increases as well. Some parents perceive that there is trauma associated with the administration of multiple injections, and researc ...
DOI:: 10.1016/j.vaccine.2015.04.020
: https://dx.doi.org/10.1016/j.vaccine.2015.04.020

53. Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents

Author:: King, James C.; Gao, Yonghong; Quinn, Conrad P.; Dreier, Thomas M.; Vianney, Cabrini; Espeland, Eric M.
Source:: Vaccine 2015 v.33 no.21 pp. 2470-2476
ISSN:: 0264-410X
Subject:: United States, etc ; Bacillus anthracis; adolescents; anthrax; antibodies; children; databases; disease control; elderly; ethics; immune response; injection site; spores; vaccination; vaccines; Show all 15 Subjects
Abstract:: ... Anthrax vaccine adsorbed (AVA, BioThrax®) is recommended for post-exposure prophylaxis administration for the US population in response to large-scale Bacillus anthracis spore exposure. However, no information exists on AVA use in children and ethical barriers exist to performing pre-event pediatric AVA studies. A Presidential Ethics Commission proposed a potential pathway for such studies utilizi ...
DOI:: 10.1016/j.vaccine.2015.03.071
: https://dx.doi.org/10.1016/j.vaccine.2015.03.071

54. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014

Author:: Karafillakis, Emilie; Hassounah, Sondus; Atchison, Christina
Source:: Vaccine 2015 v.33 no.18 pp. 2097-2107
ISSN:: 0264-410X
Subject:: United States, etc ; Rotavirus; children; clinical trials; databases; gastroenteritis; health services; public health; systematic review; vaccination; vaccines; Europe; Latin America; Show all 13 Subjects
Abstract:: ... Prior to the introduction of rotavirus vaccines in 2006, rotavirus was the leading cause of severe gastroenteritis among European children <5 years of age. We conducted a systematic review of the published literature to examine the effectiveness and impact of rotavirus vaccines in Europe following the first eight years of routine use. Four publication databases were searched, yielding 276 unique c ...
DOI:: 10.1016/j.vaccine.2015.03.016
: https://dx.doi.org/10.1016/j.vaccine.2015.03.016

55. Interventions to increase influenza vaccination rates in children with high-risk conditions—A systematic review

Author:: Aigbogun, N.W.; Hawker, J.I.; Stewart, A.
Source:: Vaccine 2015 v.33 no.6 pp. 759-770
ISSN:: 0264-410X
Subject:: United States, etc ; elderly; at-risk population; morbidity; cohort studies; vaccines; systematic review; vaccination; chronic diseases; children; asthma; mortality; randomized clinical trials; education; influenza; databases; Show all 16 Subjects
Abstract:: ... Influenza is a common cause of morbidity and mortality, especially among the elderly and those with certain chronic diseases. Annual influenza vaccination is recommended for individuals in at-risk groups, but rates of vaccination are particularly low in children with high-risk conditions (HRCs).To conduct a systematic review of studies that have examined interventions aimed at improving influenza ...
DOI:: 10.1016/j.vaccine.2014.12.013
: https://dx.doi.org/10.1016/j.vaccine.2014.12.013

56. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006

Author:: Abrams, Joseph Y.; Weintraub, Eric S.; Baggs, James M.; McCarthy, Natalie L.; Schonberger, Lawrence B.; Lee, Grace M.; Klein, Nicola P.; Belongia, Edward A.; Jackson, Michael L.; Naleway, Allison L.; Nordin, James D.; Hambidge, Simon J.; Belay, Ermias D.
Source:: Vaccine 2015 v.33 no.2 pp. 382-387
ISSN:: 0264-410X
Subject:: United States, etc ; childhood; children; disease incidence; etiology; protective effect; risk factors; vaccination; vaccines; Show all 9 Subjects
Abstract:: ... Kawasaki disease is a childhood vascular disorder of unknown etiology. Concerns have been raised about vaccinations being a potential risk factor for Kawasaki disease.Data from the Vaccine Safety Datalink were collected on children aged 0–6 years at seven managed care organizations across the United States. Defining exposure as one of several time periods up to 42 days after vaccination, we conduc ...
DOI:: 10.1016/j.vaccine.2014.10.044
: https://dx.doi.org/10.1016/j.vaccine.2014.10.044

57. Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children

Author:: Brady, Rebecca C.; Hu, Wilson; Houchin, Vonda G.; Eder, Frank S.; Jackson, Kenneth C.; Hartel, Gunter F.; Sawlwin, Daphne C.; Albano, Frank R.; Greenberg, Michael
Source:: Vaccine 2014 v.32 no.52 pp. 7141-7147
ISSN:: 0264-410X
Subject:: United States, etc ; anorexia; autumn; blood serum; children; fever; immune response; influenza; people; risk; seizures; vaccination; vaccines; Show all 13 Subjects
Abstract:: ... A trivalent inactivated influenza vaccine (CSL's TIV, CSL Limited) was licensed under USA accelerated approval regulations for use in persons ≥18 years. We performed a randomized, observer-blind study to assess the safety and immunogenicity of CSL's TIV versus an established US-licensed vaccine in a population ≥6 months to <18 years of age. Subjects were stratified as follows: Cohort A (≥6 months ...
DOI:: 10.1016/j.vaccine.2014.10.024
: https://dx.doi.org/10.1016/j.vaccine.2014.10.024

58. Interwoven support: An historical survey of US federal programs enabling immunization

Author:: Dalrymple, Dack W.; Grabenstein, John D.
Source:: Vaccine 2014 v.32 no.50 pp. 6855-6866
ISSN:: 0264-410X
Subject:: United States, etc ; accidents; adults; antibodies; children; disease outbreaks; disease surveillance; emerging diseases; endemic diseases; experts; funding; governmental programs and projects; influenza; manufacturing; product quality; purchasing; safety assessment; surveys; vaccination; vaccines; Show all 20 Subjects
Abstract:: ... The US Government (USG) can date its involvement with immunization to military and civilian efforts in 1777 and 1813 to prevent smallpox. USG involvement began accelerating with federal licensing of vaccine and antibody manufacturers in 1903. In addition to ongoing regulation of manufacturing and product quality, military and civilian arms of the USG have led research efforts into new or improved ...
DOI:: 10.1016/j.vaccine.2014.09.060
: https://dx.doi.org/10.1016/j.vaccine.2014.09.060

59. Seasonal influenza vaccination trends from 2007–2011 in privately insured children and adults in the United States

Author:: Antonova, Evgeniya; Ambrose, Christopher S.; Kern, David; Block, Stan L.; Caspard, Herve; Tunceli, Ozgur
Source:: Vaccine 2014 v.32 no.48 pp. 6563-6568
ISSN:: 0264-410X
Subject:: United States, etc ; adults; children; cohort studies; influenza; people; preservatives; vaccination; vaccines; Show all 9 Subjects
Abstract:: ... To ensure adequate protection from seasonal influenza in the US, the Advisory Committee on Immunization Practices recommends vaccination of all persons aged 6 months or older, with rare exceptions. It also advises starting vaccination as soon as available and continuing throughout the influenza season. This study examined US seasonal vaccination trends during five consecutive influenza seasons in ...
DOI:: 10.1016/j.vaccine.2014.07.009
: https://dx.doi.org/10.1016/j.vaccine.2014.07.009

60. Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: Lessons for vaccine introduction

Author:: Wallace, Aaron S.; Mantel, Carsten; Mayers, Gill; Mansoor, Osman; Gindler, Jacqueline S.; Hyde, Terri B.
Source:: Vaccine 2014 v.32 no.41 pp. 5301-5310
ISSN:: 0264-410X
Subject:: United States, etc ; adverse effects; attitudes and opinions; childhood; children; developing countries; health care workers; income; pain; parents; psychological stress; systematic review; uncertainty; vaccination; vaccines; Show all 15 Subjects
Abstract:: ... An increasing proportion of childhood immunization visits include administration of multiple injections. Future introduction of vaccines to protect against multiple diseases will further increase the number of injections at routine immunization childhood visits, particularly in developing countries that are still scaling up introductions. Parental and healthcare provider attitudes toward multiple ...
DOI:: 10.1016/j.vaccine.2014.07.076
: https://dx.doi.org/10.1016/j.vaccine.2014.07.076

61. Immunogenicity and safety of a single dose of a CRM-conjugated meningococcal ACWY vaccine in children and adolescents aged 2–18 years in Taiwan: Results of an open label study

Author:: Huang, Li-Min; Chiu, Nan-Chang; Yeh, Shu-Jen; Bhusal, Chiranjiwi; Arora, Ashwani Kumar
Source:: Vaccine 2014 v.32 no.40 pp. 5177-5184
ISSN:: 0264-410X
Subject:: United States, etc ; European Union; Neisseria meningitidis; adolescents; antibacterial properties; blood serum; children; immune response; people; serotypes; vaccination; vaccines; Italy; Taiwan; Show all 14 Subjects
Abstract:: ... MenACWY-CRM (Menveo®, Novartis Vaccines, Siena, Italy) is a quadrivalent meningococcal conjugate vaccine developed to help prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. It is approved within the European Union in persons >2 years of age and in persons from 2 months to 55 years of age in the United States, among other countries. Little is known a ...
DOI:: 10.1016/j.vaccine.2014.07.063
: https://dx.doi.org/10.1016/j.vaccine.2014.07.063

62. Prevention of group B streptococcal disease in the first 3 months of life: Would routine maternal immunization during pregnancy be cost-effective?

Author:: Oster, Gerry; Edelsberg, John; Hennegan, Kalin; Lewin, Clement; Narasimhan, Vas; Slobod, Karen; Edwards, Morven S.; Baker, Carol J.
Source:: Vaccine 2014 v.32 no.37 pp. 4778-4785
ISSN:: 0264-410X
Subject:: United States, etc ; Streptococcus agalactiae; adolescents; antibiotics; children; cost effectiveness; cost estimates; disease control; fetal death; infancy; infants; pregnancy; premature birth; quality-adjusted life year; risk reduction; screening; serotypes; vaccination; vaccines; Show all 19 Subjects
Abstract:: ... A vaccine against group B streptococcus (GBS) that is intended for routine maternal immunization during pregnancy is in clinical development. Addition of vaccination to screening and intrapartum antibiotic prophylaxis (IAP) may further reduce the burden of GBS disease in infancy; its potential cost-effectiveness is unknown, however.We evaluated the cost-effectiveness of routine immunization at wee ...
DOI:: 10.1016/j.vaccine.2014.06.003
: https://dx.doi.org/10.1016/j.vaccine.2014.06.003

63. Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys

Author:: Cates, Joan R.; Diehl, Sandra J.; Crandell, Jamie L.; Coyne-Beasley, Tamera
Source:: Vaccine 2014 v.32 no.33 pp. 4171-4178
ISSN:: 0264-410X
Subject:: United States, etc ; Papillomaviridae; adolescents; age; boys; children; demographic statistics; girls; health care workers; humans; marketing; models; parents; probability; radio; social marketing; vaccination; vaccines; Show all 18 Subjects
Abstract:: ... Adoption of human papillomavirus (HPV) vaccination in the US has been slow. In 2011, HPV vaccination of boys was recommended by CDC for routine use at ages 11–12. We conducted and evaluated a social marketing intervention with parents and providers to stimulate HPV vaccination among preteen boys.We targeted parents and providers of 9–13 year old boys in a 13 county NC region. The 3-month intervent ...
DOI:: 10.1016/j.vaccine.2014.05.044
PubMed:: 24886960
PubMed Central:: PMC4080713
: https://dx.doi.org/10.1016/j.vaccine.2014.05.044

64. Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection

Author:: Lanzieri, Tatiana M.; Bialek, Stephanie R.; Ortega-Sanchez, Ismael R.; Gambhir, Manoj
Source:: Vaccine 2014 v.32 no.30 pp. 3780-3786
ISSN:: 0264-410X
Subject:: United States, etc ; adolescents; children; mathematical models; pathogens; seroprevalence; vaccination; vaccines; women; Brazil; Show all 10 Subjects
Abstract:: ... Understanding the potential for vaccination to change cytomegalovirus (CMV) epidemiology is important for developing CMV vaccines and designing clinical trials.We constructed a deterministic, age-specific and time-dependent mathematical model of pathogen transmission, parameterized using CMV seroprevalence from the United States and Brazil, to predict the impact of vaccination on congenital CMV in ...
DOI:: 10.1016/j.vaccine.2014.05.014
PubMed:: 24837782
PubMed Central:: PMC4843116
: https://dx.doi.org/10.1016/j.vaccine.2014.05.014

65. Evaluating the potential risks and benefits of infant rotavirus vaccination in England

Author:: Clark, Andy; Jit, Mark; Andrews, Nick; Atchison, Christina; Edmunds, W. John; Sanderson, Colin
Source:: Vaccine 2014 v.32 no.29 pp. 3604-3610
ISSN:: 0264-410X
Subject:: United States, etc ; children; death; gastroenteritis; infants; risk; risk-benefit analysis; vaccination; vaccines; Australia; England; Show all 11 Subjects
Abstract:: ... Rotarix®, a vaccine for the prevention of gastroenteritis in young children, was introduced in England in July 2013. At around this time, an elevated risk of intussusception (a cause of bowel obstruction) was reported among infants vaccinated in Australia and the USA. A risk-benefit analysis compared potential vaccine-related risks (additional intussusception admissions and deaths) with estimated ...
DOI:: 10.1016/j.vaccine.2014.04.082
: https://dx.doi.org/10.1016/j.vaccine.2014.04.082

66. Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines

Author:: Jiang, Jiu; Fisher, Erin M.; Hensley, Scott E.; Lustigman, Sara; Murasko, Donna M.; Shen, Hao
Source:: Vaccine 2014 v.32 no.23 pp. 2696-2702
ISSN:: 0264-410X
Subject:: United States, etc ; adjuvants; alum; animal models; antibodies; children; elderly; humans; influenza; mutation; pandemic; surface antigens; vaccination; vaccines; Show all 14 Subjects
Abstract:: ... Influenza is one of the most common infectious diseases endangering the health of humans, especially young children and the elderly. Although vaccination is the most effective means of protection against influenza, frequent mutations in viral surface antigens, low protective efficacy of the influenza vaccine in the elderly, slow production process and the potential of vaccine supply shortage durin ...
DOI:: 10.1016/j.vaccine.2014.03.046
PubMed:: 24681229
PubMed Central:: PMC4080630
: https://dx.doi.org/10.1016/j.vaccine.2014.03.046

67. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?

Author:: Weil-Olivier, Catherine; Gaillat, Jacques
Source:: Vaccine 2014 v.32 no.18 pp. 2022-2026
ISSN:: 0264-410X
Subject:: United States, etc ; Streptococcus pneumoniae; bacteremia; children; disease control; elderly; immune response; issues and policy; meningitis; monitoring; morbidity; mortality; pneumonia; polysaccharides; risk; serotypes; vaccination; vaccines; Netherlands; Show all 19 Subjects
Abstract:: ... Before conjugate pneumococcal vaccines (PCVs) were introduced it was estimated that Streptococcus pneumoniae caused 500,000 cases of pneumonia, 50,000 cases of bacteremia and 3000 cases of meningitis annually in the United States in both children and adults. After 10 years of routine use of the 7-valent pneumococcal conjugate vaccine (PCV7) the incidence of vaccine-type pneumococcal diseases (PDs) ...
DOI:: 10.1016/j.vaccine.2014.02.008
: https://dx.doi.org/10.1016/j.vaccine.2014.02.008

68. System factors to explain 2009 pandemic H1N1 state vaccination rates for children and high-risk adults in US emergency response to pandemic

Author:: Davila-Payan, Carlo; Swann, Julie; Wortley, Pascale M.
Source:: Vaccine 2014 v.32 no.2 pp. 246-251
ISSN:: 0264-410X
Subject:: United States, etc ; adults; children; demographic statistics; funding; influenza; infrastructure; models; monitoring; pandemic; prediction; vaccination; vaccines; women; Show all 14 Subjects
Abstract:: ... During the 2009–2010 H1N1 pandemic, children and high-risk adults had priority for vaccination. Vaccine in short supply was allocated to states pro-rata by population, but vaccination rates as of January 2010 varied among states from 21.3% to 84.7% for children and 10.4% to 47.2% for high-risk adults. States had different campaign processes and decisions.To determine program and system factors ass ...
DOI:: 10.1016/j.vaccine.2013.11.018
PubMed:: 24286836
PubMed Central:: PMC6132055
: https://dx.doi.org/10.1016/j.vaccine.2013.11.018

69. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects

Author:: Davis, Stephanie M.; Deloria-Knoll, Maria; Kassa, Hilina T.; O’Brien, Katherine L.
Source:: Vaccine 2013 v.32 no.1 pp. 133-145
ISSN:: 0264-410X
Subject:: United States, etc ; Streptococcus pneumoniae; children; databases; developed countries; elderly; monitoring; morbidity; mortality; observational studies; people; randomized clinical trials; vaccination; vaccines; Australia; Show all 15 Subjects
Abstract:: ... Invasive disease due to Streptococcus pneumoniae remains an important worldwide cause of morbidity and mortality, particularly in young children and the elderly. The development and use of pneumococcal conjugate vaccines (PCVs) have had a dramatic impact on rates of vaccine-type invasive pneumococcal disease (IPD) not only in the pediatric population targeted for vaccination but in non-vaccinated ...
DOI:: 10.1016/j.vaccine.2013.05.005
: https://dx.doi.org/10.1016/j.vaccine.2013.05.005

70. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS

Author:: Halsey, Neal A.; Griffioen, Mari; Dreskin, Stephen C.; Dekker, Cornelia L.; Wood, Robert; Sharma, Devindra; Jones, James F.; LaRussa, Philip S.; Garner, Jenny; Berger, Melvin; Proveaux, Tina; Vellozzi, Claudia; Broder, Karen; Setse, Rosanna; Pahud, Barbara; Hrncir, David; Choi, Howard; Sparks, Robert; Williams, Sarah Elizabeth; Engler, Renata J.; Gidudu, Jane; Baxter, Roger; Klein, Nicola; Edwards, Kathryn; Cano, Maria; Kelso, John M.
Source:: Vaccine 2013 v.31 no.51 pp. 6107-6112
ISSN:: 0264-410X
Subject:: United States, etc ; adults; anaphylaxis; anxiety; children; epinephrine; experts; females; guidelines; influenza; live vaccines; males; men; nurses; pandemic; patients; physicians; risk; syncope; systematic review; vaccination; Show all 21 Subjects
Abstract:: ... Hypersensitivity disorders following vaccinations are a cause for concern.To determine the type and rate by age, gender, and vaccine received for reported hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines.A systematic review of reports to the Vaccine Adverse Event Reporting System (VAERS) following monovalent 2009 pandemic influenza A (H1N1) vaccines.US Civi ...
DOI:: 10.1016/j.vaccine.2013.09.066
: https://dx.doi.org/10.1016/j.vaccine.2013.09.066

71. Identification of seizures among adults and children following influenza vaccination using health insurance claims data

Author:: Thyagarajan, Veena; Su, Sue; Gee, Julianne; Duffy, Jonathan; McCarthy, Natalie L.; Chan, K. Arnold; Weintraub, Eric S.; Lin, Nancy D.
Source:: Vaccine 2013 v.31 no.50 pp. 5997-6002
ISSN:: 0264-410X
Subject:: United States, etc ; algorithms; children; databases; elderly; health insurance; health services; influenza; monitoring; risk; seizures; vaccination; vaccines; young adults; Show all 14 Subjects
Abstract:: ... Post-licensure surveillance of adverse events following vaccination or prescription drug use often relies on electronic healthcare data to efficiently detect and evaluate safety signals. The accuracy of seizure-related diagnosis codes in identifying true incident seizure events in vaccine safety studies is influenced by factors such as clinical setting of diagnosis and age. To date, most studies o ...
DOI:: 10.1016/j.vaccine.2013.10.026
: https://dx.doi.org/10.1016/j.vaccine.2013.10.026

72. Use of near-real-time medical claims data to generate timely vaccine coverage estimates in the US: The dynamics of PCV13 vaccine uptake

Author:: Schuck-Paim, Cynthia; Taylor, Robert; Lindley, David; Klugman, Keith P.; Simonsen, Lone
Source:: Vaccine 2013 v.31 no.50 pp. 5983-5988
ISSN:: 0264-410X
Subject:: United States, etc ; childhood; children; databases; information systems; models; monitoring; physicians; serotypes; surveys; toddlers; vaccination; vaccines; Show all 13 Subjects
Abstract:: ... Vaccine coverage estimates lag by years in the US. Commercially available medical claims databases contain timely records of childhood vaccinations given in physician offices. We used such data to track the replacement of the 7-valent pneumococcal conjugate vaccine (PCV7) by PCV13, a new vaccine active against 6 additional serotypes, starting in March 2010.We developed an age cohort model to compu ...
DOI:: 10.1016/j.vaccine.2013.10.038
: https://dx.doi.org/10.1016/j.vaccine.2013.10.038

73. Well-woman visit of mothers and human papillomavirus vaccine intent and uptake among their 9–17 year old children

Author:: Rahman, Mahbubur; Elam, Lee B.; Balat, Michael I.; Berenson, Abbey B.
Source:: Vaccine 2013 v.31 no.47 pp. 5544-5548
ISSN:: 0264-410X
Subject:: United States, etc ; Papillomaviridae; adolescents; children; daughters; humans; mothers; patients; physicians; questionnaires; regression analysis; sociodemographic characteristics; sons; vaccination; vaccines; women; Show all 16 Subjects
Abstract:: ... To examine the association between attending a well-woman clinic in the prior 2 years and obtaining the human papillomavirus (HPV) vaccine for their 9–17-year-old child.Women (n=1256) who attended reproductive health clinics during September 2011 to February 2013 and had ≥1 children 9–17 years of age were asked to complete a self-administered questionnaire containing questions on demographic chara ...
DOI:: 10.1016/j.vaccine.2013.09.017
PubMed:: 24099869
PubMed Central:: PMC3947530
: https://dx.doi.org/10.1016/j.vaccine.2013.09.017

74. Respiratory syncytial virus immunization program for the United States: Impact of performance determinants of a theoretical vaccine

Author:: Régnier, Stephane A.
Source:: Vaccine 2013 v.31 no.40 pp. 4347-4354
ISSN:: 0264-410X
Subject:: United States, etc ; children; complications (disease); disease control; economic costs; economic impact; economic valuation; half life; health services; immunity; income; infant mortality; models; neonates; quality-adjusted life year; risk; vaccination; vaccine development; vaccines; viruses; Show all 20 Subjects
Abstract:: ... To inform strategic decisions on respiratory syncytial virus (RSV) vaccine development and identify critical endpoints likely to drive the vaccine's medical and economic impact.A decision-analysis model populated using healthcare utilization data and costs from the literature; vaccine efficacy and duration based on assumptions.Vaccination in the physician office setting in the USA.A hypothetical c ...
DOI:: 10.1016/j.vaccine.2013.07.024
: https://dx.doi.org/10.1016/j.vaccine.2013.07.024

75. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

Author:: Jackson, Lisa A.; Gurtman, Alejandra; van Cleeff, Martin; Jansen, Kathrin U.; Jayawardene, Deepthi; Devlin, Carmel; Scott, Daniel A.; Emini, Emilio A.; Gruber, William C.; Schmoele-Thoma, Beate
Source:: Vaccine 2013 v.31 no.35 pp. 3577-3584
ISSN:: 0264-410X
Subject:: United States, etc ; Streptococcus pneumoniae; adults; children; immune response; morbidity; mortality; serotypes; vaccination; vaccines; Show all 10 Subjects
Abstract:: ... Streptococcus pneumoniae is a major cause of morbidity and mortality among adults 50 years of age and older in the United States. Pneumococcal conjugate vaccines are efficacious against pneumococcal disease in children and may also offer advantages in adults.We performed a randomized, modified double-blind trial that compared a single dose of 13-valent pneumococcal conjugate vaccine (PCV13) with 2 ...
DOI:: 10.1016/j.vaccine.2013.04.085
: https://dx.doi.org/10.1016/j.vaccine.2013.04.085

76. HPV vaccination among adolescent males: Results from the National Immunization Survey-Teen

Author:: Reiter, Paul L.; Gilkey, Melissa B.; Brewer, Noel T.
Source:: Vaccine 2013 v.31 no.26 pp. 2816-2821
ISSN:: 0264-410X
Subject:: United States, etc ; Hispanics; adolescents; children; guidelines; health care workers; health insurance; males; parents; regression analysis; sons; vaccination; vaccines; Show all 13 Subjects
Abstract:: ... US guidelines provided a permissive recommendation for HPV vaccine for males in 2009, with an updated recommendation for routine vaccination in 2011. Data on vaccine uptake among males, however, remain sparse. We analyzed 2010–2011 data (collected mostly prior to the recommendation for routine vaccination) from the National Immunization Survey-Teen for a nationally representative sample of adolesc ...
DOI:: 10.1016/j.vaccine.2013.04.010
PubMed:: 23602667
PubMed Central:: PMC3672374
: https://dx.doi.org/10.1016/j.vaccine.2013.04.010

77. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children

Author:: Tseng, Hung Fu; Sy, Lina S.; Liu, In-Lu Amy; Qian, Lei; Marcy, S. Michael; Weintraub, Eric; Yih, Katherine; Baxter, Roger; Glanz, Jason M.; Donahue, James; Naleway, Allison; Nordin, James; Jacobsen, Steven J.
Source:: Vaccine 2013 v.31 no.22 pp. 2578-2583
ISSN:: 0264-410X
Subject:: United States, etc ; anaphylaxis; asthma; at-risk population; childhood; children; cohort studies; confidence interval; edema; encephalopathy; experimental design; monitoring; relative risk; seizures; thrombocytopenia; urticaria; vaccination; vaccines; Show all 18 Subjects
Abstract:: ... Although no increased risk was detected for serious adverse events in the prelicensure trials for the 13-valent pneumococcal vaccine, Prevnar 13® (PCV13), continued monitoring of rare but serious adverse events is necessary. A surveillance system using cohort study design was set up to monitor safety of PCV13 immediately after it was included in the childhood immunization program in the United Sta ...
DOI:: 10.1016/j.vaccine.2013.03.040
: https://dx.doi.org/10.1016/j.vaccine.2013.03.040

78. Trends in vaccination coverage disparities among children, United States, 2001–2010

Author:: Zhao, Zhen; Smith, Philip J.
Source:: Vaccine 2013 v.31 no.19 pp. 2324-2327
ISSN:: 0264-410X
Subject:: United States, etc ; children; people; sociodemographic characteristics; surveys; vaccination; vaccines; Show all 7 Subjects
Abstract:: ... One of two overarching goals of the Healthy People 2010 initiative was to eliminate health disparities. We evaluate trends in children vaccination coverage disparities by socio-demographic characteristics in the United States from 2001 through 2010.Disparities in vaccination coverage for the 4:3:1:3:3:1 vaccine series was assessed with National Immunization Survey (NIS) 2001–2010 data. The dispari ...
DOI:: 10.1016/j.vaccine.2013.03.018
: https://dx.doi.org/10.1016/j.vaccine.2013.03.018

79. A systematic review of rubella vaccination strategies implemented in the Americas: impact on the incidence and seroprevalence rates of rubella and congenital rubella syndrome

Author:: Mongua-Rodriguez, Norma; Díaz-Ortega, José Luis; García-García, Lourdes; Piña-Pozas, Maricela; Ferreira-Guerrero, Elizabeth; Delgado-Sánchez, Guadalupe; Ferreyra-Reyes, Leticia; Cruz-Hervert, Luis Pablo; Baez-Saldaña, Renata; Campos-Montero, Rogelio
Source:: Vaccine 2013 v.31 no.17 pp. 2145-2151
ISSN:: 0264-410X
Subject:: United States, etc ; adults; biological resistance; boys; childhood; children; clinical trials; cohort studies; databases; girls; guidelines; mathematical models; men; risk; seroprevalence; systematic review; vaccination; vaccines; women; Argentina; Brazil; Costa Rica; Mexico; Show all 23 Subjects
Abstract:: ... To evaluate the impact of rubella vaccination strategies on the rates of acquired rubella and congenital rubella syndrome in the Americas.We conducted a systematic review of the literature (MEDLINE, PubMed, EMBASE, Cochrane Library, Artemisa Database, LILACS Database, Evidence Portal, VHL-PAHO Portal, Scielo, and Grey-Literature sources) that was published from 1969–2010. We included studies on ru ...
DOI:: 10.1016/j.vaccine.2013.02.047
: https://dx.doi.org/10.1016/j.vaccine.2013.02.047

80. Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children

Author:: Raczniak, Gregory A.; Thomas, Timothy K.; Bulkow, Lisa R.; Negus, Susan E.; Zanis, Carolyn L.; Bruce, Michael G.; Spradling, Philip R.; Teshale, Eyasu H.; McMahon, Brian J.
Source:: Vaccine 2013 v.31 no.17 pp. 2152-2155
ISSN:: 0264-410X
Subject:: United States, etc ; adults; childhood; children; hepatitis A; people; risk; vaccination; vaccines; Show all 9 Subjects
Abstract:: ... Hepatitis A is mostly a self-limiting disease but causes substantial economic burden. Consequently, United States Advisory Committee for Immunization Practices recommends inactivated hepatitis A vaccination for all children beginning at age 1 year and for high risk adults. The hepatitis A vaccine is highly effective but the duration of protection is unknown.We examined the proportion of children w ...
DOI:: 10.1016/j.vaccine.2013.02.048
PubMed:: 23470239
PubMed Central:: PMC4648811
: https://dx.doi.org/10.1016/j.vaccine.2013.02.048

81. A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24–59 months of age

Author:: Toback, Seth L.; Ambrose, Christopher S.; Eaton, Abigail; Hansen, John; Aukes, Laurie; Lewis, Ned; Wu, Xionghua; Baxter, Roger
Source:: Vaccine 2013 v.31 no.14 pp. 1812-1818
ISSN:: 0264-410X
Subject:: United States, etc ; anaphylaxis; asthma; children; clinical trials; influenza; vaccination; vaccines; Show all 8 Subjects
Abstract:: ... In the United States, live attenuated influenza vaccine (LAIV) was initially approved for use in individuals aged 5–49 years in 2003, which was extended to individuals aged 2–49 years in 2007. At that time, a postlicensure commitment was made to describe the safety of LAIV within a cohort of eligible children aged 2–5 years.A prospective observational postmarketing study was conducted to evaluate ...
DOI:: 10.1016/j.vaccine.2013.01.055
: https://dx.doi.org/10.1016/j.vaccine.2013.01.055

82. Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data

Author:: Goldman, G.S.; King, P.G.
Source:: Vaccine 2013 v.31 no.13 pp. 1680-1694
ISSN:: 0264-410X
Subject:: United States, etc ; Centers for Disease Control and Prevention; adults; case studies; children; cost benefit analysis; cost effectiveness; health services; innate immunity; monitoring; morbidity; natural history; vaccination; vaccines; Show all 14 Subjects
Abstract:: ... In a cooperative agreement starting January 1995, prior to the FDA's licensure of the varicella vaccine on March 17, the Centers for Disease Control and Prevention (CDC) funded the Los Angeles Department of Health Services’ Antelope Valley Varicella Active Surveillance Project (AV-VASP). Since only varicella case reports were gathered, baseline incidence data for herpes zoster (HZ) or shingles was ...
DOI:: 10.1016/j.vaccine.2012.05.050
PubMed:: 22659447
PubMed Central:: PMC3759842
: https://dx.doi.org/10.1016/j.vaccine.2012.05.050

83. Re-emergence of diphtheria and pertussis: Implications for Nigeria

Author:: Sadoh, A.E.; Oladokun, R.E.
Source:: Vaccine 2012 v.30 no.50 pp. 7221-7228
ISSN:: 0264-410X
Subject:: United States, etc ; adolescents; adults; childhood; children; developing countries; disease control; grandparents; health care workers; immunity; infants; monitoring; morbidity; mortality; tetanus; vaccination; vaccines; Nigeria; Show all 18 Subjects
Abstract:: ... In the prevaccine era pertussis and diphtheria were responsible for significant morbidity and mortality in children. In the United States of America more than 125,000 cases of diphtheria with 10,000 deaths were reported annually in the 1920s. In the same period about 1.7million cases of pertussis with 73,000 deaths were also reported. Vaccination against these two diseases has caused remarkable re ...
DOI:: 10.1016/j.vaccine.2012.10.014
: http://dx.doi.org/10.1016/j.vaccine.2012.10.014

84. 7-Valent pneumococcal conjugate vaccine and otitis media: Effectiveness of a 2-dose versus 3-dose primary series

Author:: Stoecker, Charles; Hampton, Lee M.; Moore, Matthew R.
Source:: Vaccine 2012 v.30 no.44 pp. 6256-6262
ISSN:: 0264-410X
Subject:: United States, etc ; children; cost effectiveness; databases; insurance; otitis media; vaccination; vaccines; Show all 8 Subjects
Abstract:: ... BACKGROUND: Seven-valent pneumococcal conjugate vaccination (PCV7) has been shown to reduce rates of otitis media (OM) when given as a 2- or 3-dose primary series followed by a booster dose. However, data on the 2- or 3-dose primary series’ relative effectiveness against OM is very limited. Using data from the United States after the 2000 introduction of PCV7, we compared the effectiveness of a 2- ...
DOI:: 10.1016/j.vaccine.2012.08.011
: http://dx.doi.org/10.1016/j.vaccine.2012.08.011

85. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season

Author:: Tennis, Patricia; Toback, Seth L.; Andrews, Elizabeth B.; McQuay, Lisa J.; Ambrose, Christopher S.
Source:: Vaccine 2012 v.30 no.42 pp. 6099-6102
ISSN:: 0264-410X
Subject:: United States, etc ; asthma; children; immunocompetence; influenza; risk; vaccination; vaccines; Show all 8 Subjects
Abstract:: ... The 2007 US approval for use of Ann Arbor strain live attenuated influenza vaccine (LAIV) in children aged 24 through 59 months included precautions against use in (1) children <24 months and children aged 24 through 59 months with (2) asthma, (3) recurrent wheezing, and (4) altered immunocompetence. Results from the third season (2009–2010) of a 3-year study postmarketing commitment to monitor LA ...
DOI:: 10.1016/j.vaccine.2012.07.031
: http://dx.doi.org/10.1016/j.vaccine.2012.07.031

86. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years

Author:: Weycker, Derek; Sato, Reiko; Strutton, David; Edelsberg, John; Atwood, Mark; Jackson, Lisa A.
Source:: Vaccine 2012 v.30 no.36 pp. 5437-5444
ISSN:: 0264-410X
Subject:: United States, etc ; children; economic impact; elderly; health care costs; models; pneumonia; public health; risk; vaccination; vaccines; Show all 11 Subjects
Abstract:: ... BACKGROUND: A 13-valent pneumococcal conjugate vaccine (PCV13) was recently developed for use in older adults, and may be effective not only against invasive pneumococcal disease (IPD) but also nonbacteremic pneumococcal pneumonia. The potential public health and economic impact of PCV13 in this population is unknown. METHODS: A microsimulation model depicting risk and costs of IPD and all-cause n ...
DOI:: 10.1016/j.vaccine.2012.05.076
: http://dx.doi.org/10.1016/j.vaccine.2012.05.076

87. Variation in adult vaccination policies across Europe: An overview from VENICE network on vaccine recommendations, funding and coverage

Author:: Kanitz, Elisabeth E.; Wu, Lauren A.; Giambi, Cristina; Strikas, Raymond A.; Levy-Bruhl, Daniel; Stefanoff, Pawel; Mereckiene, Jolita; Appelgren, Eva; D’Ancona, Fortunato
Source:: Vaccine 2012 v.30 no.35 pp. 5222-5228
ISSN:: 0264-410X
Subject:: United States, etc ; questionnaires; funding; at-risk population; tetanus; vaccines; surveys; hepatitis B; European Union; adulthood; children; adults; vaccination; influenza; issues and policy; developed countries; Europe; Show all 17 Subjects
Abstract:: ... BACKGROUND: In 2010–2011, in the framework of the VENICE project, we surveyed European Union (EU) and Economic Area (EEA) countries to fill the gap of information regarding vaccination policies in adults. This project was carried out in collaboration with the United States National Vaccine Program Office, who conducted a similar survey in all developed countries. METHODS: VENICE representatives of ...
DOI:: 10.1016/j.vaccine.2012.06.012
: http://dx.doi.org/10.1016/j.vaccine.2012.06.012

88. The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence

Author:: Usonis, Vytautas; Ivaskeviciene, Inga; Desselberger, Ulrich; Rodrigo, Carlos
Source:: Vaccine 2012 v.30 no.31 pp. 4596-4605
ISSN:: 0264-410X
Subject:: United States, etc ; Rotavirus A; children; developed countries; gastroenteritis; genotype; monitoring; neutralizing antibodies; surveys; vaccination; vaccines; Australia; Brazil; Europe; Show all 14 Subjects
Abstract:: ... This article reviews the incidence of group A rotavirus (RV) types isolated from children with acute gastroenteritis (AGE) in European countries during the last 5–10 years, with the aim of establishing an overview of RV diversity before the introduction of universal mass vaccination (UMV) programmes against RV disease in most European countries. Consistent with findings from previous surveys, a hi ...
DOI:: 10.1016/j.vaccine.2012.04.097
: http://dx.doi.org/10.1016/j.vaccine.2012.04.097

89. Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States

Author:: Santibanez, Tammy A.; Shefer, Abigail; Briere, Elizabeth C.; Cohn, Amanda C.; Groom, Amy V.
Source:: Vaccine 2012 v.30 no.5 pp. 941-947
ISSN:: 0264-410X
Subject:: United States, etc ; Haemophilus influenzae; children; sociodemographic characteristics; surveys; vaccination; vaccines; Show all 7 Subjects
Abstract:: ... BACKGROUND: A shortage of Haemophilus influenzae type b (Hib) vaccine that occurred in the United States during December 2007 to September 2009 resulted in an interim recommendation to defer the booster dose, but to continue to vaccinate as recommended with the primary series during the first year of life. OBJECTIVES: To quantify effects of the Hib shortage on vaccination coverage and to determine ...
DOI:: 10.1016/j.vaccine.2011.11.075
: http://dx.doi.org/10.1016/j.vaccine.2011.11.075

90. An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP–IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children

Author:: Klein, Nicola P.; Weston, Wayde M.; Kuriyakose, Sherine; Kolhe, Devayani; Howe, Barbara; Friedland, Leonard R.; Van Der Meeren, Olivier
Source:: Vaccine 2012 v.30 no.3 pp. 668-674
ISSN:: 0264-410X
Subject:: United States, etc ; Enterovirus C; antigens; children; immune response; influenza; tetanus; vaccination; vaccines; Show all 9 Subjects
Abstract:: ... BACKGROUND: In the US, it is recommended that 4–6 year old children receive diphtheria–tetanus–acellular pertussis (DTaP), inactivated poliovirus (IPV), measles–mumps–rubella (MMR), varicella (V), and influenza vaccines. Data relating to the concomitant administration of combination DTaP–IPV vaccine (Kinrix™; GlaxoSmithKline Biologicals) and influenza or V vaccines are currently limited. This stud ...
DOI:: 10.1016/j.vaccine.2011.10.065
: http://dx.doi.org/10.1016/j.vaccine.2011.10.065

91. Validity of parental report of influenza vaccination in young children seeking medical care

Author:: Brown, Cedric; Clayton-Boswell, Haley; Chaves, Sandra S.; Prill, Mila M.; Iwane, Marika K.; Szilagyi, Peter G.; Edwards, Kathryn M.; Staat, Mary A.; Weinberg, Geoffrey A.; Fairbrother, Gerry; Hall, Caroline B.; Zhu, Yuwei; Bridges, Carolyn B.
Source:: Vaccine 2011 v.29 no.51 pp. 9488-9492
ISSN:: 0264-410X
Subject:: United States, etc ; children; health insurance; higher education; hospitals; influenza; nationalities and ethnic groups; parents; surveys; vaccination; vaccines; Show all 11 Subjects
Abstract:: ... BACKGROUND: Despite frequent use of self-reported information to determine pediatric influenza vaccination coverage, little data are available on the validity of parental reporting of their child's influenza vaccination status and on factors affecting its accuracy. METHODS: We compared parent reported influenza vaccination of children to documented reports of vaccination collected from medical rec ...
DOI:: 10.1016/j.vaccine.2011.10.023
: http://dx.doi.org/10.1016/j.vaccine.2011.10.023

92. Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited

Author:: Vadaparampil, Susan T.; Kahn, Jessica A.; Salmon, Daniel; Lee, Ji-Hyun; Quinn, Gwendolyn P.; Roetzheim, Richard; Bruder, Karen; Malo, Teri L.; Proveaux, Tina; Zhao, Xiuhua; Halsey, Neal; Giuliano, Anna R.
Source:: Vaccine 2011 v.29 no.47 pp. 8634-8641
ISSN:: 0264-410X
Subject:: United States, etc ; Papillomaviridae; adolescents; children; females; girls; humans; issues and policy; multivariate analysis; nationalities and ethnic groups; patients; pediatricians; surveys; vaccination; vaccines; young adults; Show all 16 Subjects
Abstract:: ... OBJECTIVE: The purpose of this study was to determine the prevalence of physician recommendation of human papillomavirus (HPV) vaccination in early (ages 11–12), middle (13–17), and late adolescent/young adult (18–26) female patients by physician specialty, and to identify factors associated with recommendation in early adolescents. METHODS: A 38-item survey was conducted April 2009 through August ...
DOI:: 10.1016/j.vaccine.2011.09.006
PubMed:: 21924315
PubMed Central:: PMC3200426
: http://dx.doi.org/10.1016/j.vaccine.2011.09.006

93. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US

Author:: Shea, K.M.; Weycker, D.; Stevenson, A.E.; Strutton, D.R.; Pelton, S.I.
Source:: Vaccine 2011 v.29 no.45 pp. 8042-8048
ISSN:: 0264-410X
Subject:: United States, etc ; children; disease prevalence; models; nasopharynx; otitis media; serotypes; vaccination; vaccines; Show all 9 Subjects
Abstract:: ... We hypothesized that following the introduction of PCV7, the exchange of vaccine serotypes (VST) for non-vaccine serotypes (NVST) in the nasopharynx has resulted in fewer episodes of pneumococcal acute otitis media (AOM) due to the reduced capacity for common NVST strains to cause disease. We modeled the change in the proportion of children colonized with S. pneumoniae who would develop pneumococc ...
DOI:: 10.1016/j.vaccine.2011.08.057
: http://dx.doi.org/10.1016/j.vaccine.2011.08.057

94. Hepatitis B vaccination coverage among high-risk adults 18–49 years, U.S., 2009

Author:: Lu, Peng-jun; Byrd, Kathy K.; Murphy, Trudy V.; Weinbaum, Cindy
Source:: Vaccine 2011 v.29 no.40 pp. 7049-7057
ISSN:: 0264-410X
Subject:: United States, etc ; Hepatitis B virus; vaccination; adults; relative risk; adolescents; sexually transmitted diseases; females; men; risk factors; hepatitis B; children; blood coagulation factors; higher education; vaccines; surveys; health care workers; regression analysis; drug injection; influenza; hemophilia; Show all 21 Subjects
Abstract:: ... BACKGROUND: Approximately 43,000 new hepatitis B virus (HBV) infections occurred in 2007. Although hepB vaccination has been recommended for adults at high-risk for incident HBV infection for many years, coverage remains low. METHODS: We used the 2009 National Health Interview Survey to assess self-reported HepB vaccine uptake (≥1 dose), series completion (≥3 dose), and independent predictors of v ...
DOI:: 10.1016/j.vaccine.2011.07.030
: http://dx.doi.org/10.1016/j.vaccine.2011.07.030

95. The future of pneumococcal disease prevention

Author:: Rodgers, Gail L.; Klugman, Keith P.
Source:: Vaccine 2011 v.29S3 pp. C43
ISSN:: 0264-410X
Subject:: United States, etc ; burden of disease; children; clinical trials; disease prevention; immune response; mortality; otitis media; pneumonia; proteins; serotypes; vaccination; vaccines; Caribbean; Show all 14 Subjects
Abstract:: ... Pneumococcal disease (PD) is the leading cause of vaccine preventable deaths in children <5 years of age worldwide, with most of the deaths occurring in the developing world. Prevention of PD in children has been achieved by vaccination with pneumococcal conjugate vaccine (PCV), the basis for which is induction of a protective antibody response against the bacterial polysaccharide capsule. Conjuga ...
DOI:: 10.1016/j.vaccine.2011.07.047
: http://dx.doi.org/10.1016/j.vaccine.2011.07.047

96. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America

Author:: Giglio, Norberto; Micone, Paula; Gentile, Angela
Source:: Vaccine 2011 v.29S3 pp. C35
ISSN:: 0264-410X
Subject:: United States, etc ; Streptococcus pneumoniae; bacterial infections; children; complications (disease); cost effectiveness; developed countries; developing countries; disability-adjusted life year; economic impact; economic valuation; herds; immunity; mortality; otitis media; pneumonia; quality-adjusted life year; serotypes; uncertainty; vaccination; vaccines; Europe; Latin America; Show all 23 Subjects
Abstract:: ... Streptococcus pneumoniae continues to be the most important causative agent of invasive bacterial infections in children and is the most common cause of vaccine-preventable deaths in children less than 5 years of age. Due to some conditions in the Latin America region, economic assessments of pneumococcal conjugate vaccines (PCVs) have unique characteristics. First, distribution of S. pneumoniae s ...
DOI:: 10.1016/j.vaccine.2011.06.095
: http://dx.doi.org/10.1016/j.vaccine.2011.06.095

97. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines

Author:: Tyo, Karen Richards; Rosen, Melissa M.; Zeng, Wu; Yap, Mabel; Pwee, Keng Ho; Ang, Li Wei; Shepard, Donald S.
Source:: Vaccine 2011 v.29 no.38 pp. 6686-6694
ISSN:: 0264-410X
Subject:: United States, etc ; World Health Organization; bacteremia; childhood; children; cost effectiveness; cost estimates; disease incidence; herds; immunity; infants; meningitis; otitis media; pneumonia; public health; quality-adjusted life year; serotypes; simulation models; vaccination; vaccines; Singapore; Show all 21 Subjects
Abstract:: ... INTRODUCTION: Although multiple studies of cost-effectiveness of pneumococcal conjugate vaccines have been conducted, no such study has examined Singapore's situation nor compared the licensed conjugate vaccines in an Asian population. This paper estimates the costs and public health impacts of pneumococcal conjugate vaccine programs, varying estimates of serotype replacement and herd immunity eff ...
DOI:: 10.1016/j.vaccine.2011.06.091
: http://dx.doi.org/10.1016/j.vaccine.2011.06.091

98. Bacterial etiology and serotypes of acute otitis media in Mexican children

Author:: Parra, Mercedes Macias; Aguilar, Gerardo Martinez; Echaniz-Aviles, Gabriela; Rionda, Romulo Galo; de Los Angeles Meza Estrada, Maria; Cervantes, Yolanda; Pirçon, Jean-Yves; Van Dyke, Melissa K.; Colindres, Romulo E.; Hausdorff, William P.
Source:: Vaccine 2011 v.29 no.33 pp. 5544-5549
ISSN:: 0264-410X
Subject:: United States, etc ; Haemophilus influenzae; Mexicans; Streptococcus pneumoniae; amoxicillin; antibiotic resistance; cefuroxime; children; epidemiological studies; otitis media; pathogens; serotypes; vaccination; vaccines; Europe; Latin America; Show all 16 Subjects
Abstract:: ... Streptococcus pneumoniae and Haemophilus influenzae have been consistently reported to be the two major bacterial pathogens responsible for acute otitis media (AOM), mainly from studies in the US and Europe. However, data on bacterial pathogens causing AOM in Latin America are limited. Understanding the relative importance of these pathogens in a specific setting, the serotype distribution, and th ...
DOI:: 10.1016/j.vaccine.2011.04.128
: http://dx.doi.org/10.1016/j.vaccine.2011.04.128

99. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years

Author:: Tennis, Patricia; Toback, Seth L.; Andrews, Elizabeth; McQuay, Lisa J.; Ambrose, Christopher S.
Source:: Vaccine 2011 v.29 no.31 pp. 4947-4952
ISSN:: 0264-410X
Subject:: United States, etc ; asthma; children; databases; guidelines; health insurance; immunocompetence; influenza; vaccination; vaccines; Show all 10 Subjects
Abstract:: ... The 2007 US approval for use of live attenuated influenza vaccine (LAIV) in children aged 24–59 months included precautions against use in (1) children <24 months and children aged 24–59 months with (2) asthma, (3) recurrent wheezing, and (4) altered immunocompetence. A postmarketing commitment was initiated to monitor LAIV use and the frequency of select safety outcomes in these cohorts. Vaccinat ...
DOI:: 10.1016/j.vaccine.2011.04.113
: http://dx.doi.org/10.1016/j.vaccine.2011.04.113

100. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review

Author:: Thomas, Roger E.; Lorenzetti, Diane L.; Spragins, Wendy; Jackson, Dave; Williamson, Tyler
Source:: Vaccine 2011 v.29 no.28 pp. 4544-4555
ISSN:: 0264-410X
Subject:: United States, etc ; Yellow fever virus; anaphylaxis; children; databases; developed countries; histopathology; infants; languages; monitoring; mortality; nervous system diseases; patients; polymerase chain reaction; pregnant women; systematic review; urticaria; vaccination; vaccines; Australia; Brazil; Switzerland; United Kingdom; Show all 23 Subjects
Abstract:: ... PURPOSE: To identify the rate of serious adverse events attributable to yellow fever vaccination with 17D and 17DD strains reported in active and passive surveillance data. METHODS: We conducted a systematic review of published literature on adverse events associated with yellow fever. We searched 9 electronic databases for peer reviewed and grey literature in all languages. There were no restrict ...
DOI:: 10.1016/j.vaccine.2011.04.055
: http://dx.doi.org/10.1016/j.vaccine.2011.04.055

PubAg

Main content area

Limit your search

Text Availability

Journal

Publication Year

Subject

Search

108 Search Results

Search Results

1. Physician clinical decision support system prompts and administration of subsequent doses of HPV vaccine: A randomized clinical trial

2. Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia

3. Variation in rotavirus vaccination coding in state US Medicaid data

4. Associations between population based voting trends during the 2016 US presidential election and adolescent vaccination rates

5. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015–2016

6. Trends in U.S. Community hospitalizations due to herpes zoster: 2001–2015

7. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008–2016)

8. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14–26 year old females in the U.S.

9. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012–2016

10. Examination of universal purchase programs as a driver of vaccine uptake among US States, 1995–2014

11. An innovative medical school curriculum to address human papillomavirus vaccine hesitancy

12. Pharmacies versus doctors’ offices for adolescent vaccination

13. “When you are injected, the baby is protected:” Assessing the acceptability of a maternal Tdap vaccine based on mothers’ knowledge, attitudes, and beliefs of pertussis and vaccinations in Lusaka, Zambia

14. Vaccine delivery to newly arrived refugees and estimated costs in selected U.S. clinics, 2015

15. Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older

16. Vaccination coverage among foreign-born and U.S.-born adolescents in the United States: Successes and gaps – National Immunization Survey-Teen, 2012–2014

17. Hepatitis A vaccination coverage among adolescents (13–17 years) in the United States, 2008–2016

18. Parent perceptions of dentists’ role in HPV vaccination

19. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015

20. Public health impact of Rotarix vaccination among commercially insured children in the United States

21. Semantic network analysis of vaccine sentiment in online social media

22. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants

23. Missed opportunities for simultaneous administration of the fourth dose of DTaP among children in the United States

24. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014–2015 season

25. Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010–2012

26. Vaccine strategies: Optimising outcomes

27. Uptake of rotavirus vaccine among US infants at Immunization Information System Sentinel Sites

28. Parental experiences with vaccine information statements: Implications for timing, delivery, and parent-provider immunization communication

29. Trends in childhood vaccine purchase costs in the US public sector: 1996–2014

30. Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children

31. Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers

32. Hurdles to herd immunity: Distrust of government and vaccine refusal in the US, 2002–2003

33. Evaluation of potentially achievable vaccination coverage with simultaneous administration of vaccines among children in the United States

34. Reasons given for not receiving an influenza vaccination, 2011–12 influenza season, United States

35. Challenges to health workers and their opinions about parents’ refusal of oral polio vaccination in the Khyber Pakhtoon Khawa (KPK) province, Pakistan

36. Epidemiology of rubella and congenital rubella syndrome in Japan before 1989

37. Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease

38. Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996–2011

39. Completion and compliance of childhood vaccinations in the United States

40. Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010–13, United States

41. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2–17 years of age in 2013–2014 in the United States

42. Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009

43. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines

44. Vaccine hesitancy

45. Maternal benefits of immunization during pregnancy

46. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons

47. Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011−12 through 2013−14 influenza seasons

48. Estimating the herd immunity effect of rotavirus vaccine

49. Deaths following vaccination: What does the evidence show?

50. Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents

51. Effect of multiple, simultaneous vaccines on polio seroresponse and associated health outcomes

52. Immune overload: Parental attitudes toward combination and single antigen vaccines

53. Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents

54. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014

55. Interventions to increase influenza vaccination rates in children with high-risk conditions—A systematic review

56. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006

57. Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children

58. Interwoven support: An historical survey of US federal programs enabling immunization

59. Seasonal influenza vaccination trends from 2007–2011 in privately insured children and adults in the United States

60. Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: Lessons for vaccine introduction

61. Immunogenicity and safety of a single dose of a CRM-conjugated meningococcal ACWY vaccine in children and adolescents aged 2–18 years in Taiwan: Results of an open label study

62. Prevention of group B streptococcal disease in the first 3 months of life: Would routine maternal immunization during pregnancy be cost-effective?

63. Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys

64. Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection

65. Evaluating the potential risks and benefits of infant rotavirus vaccination in England

66. Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines

67. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?

68. System factors to explain 2009 pandemic H1N1 state vaccination rates for children and high-risk adults in US emergency response to pandemic

69. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects

70. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS

8. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14–26 year old females in the U.S.

15. Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older

17. Hepatitis A vaccination coverage among adolescents (13–17 years) in the United States, 2008–2016